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Micro free flow electrophoresis (µFFE) is a separation technique which 
can be used for unique applications due to its continuous nature. Separations are 
performed in space, as opposed to time, as laminar flow drives analytes down 
the separation chamber and are separated laterally by an electric field. This 
continuous nature makes it an attractive option to be used as a second 
dimension in multidimensional separations. The major focus of this work will be 
the development of a 2D separation platform coupling a commercial nano-liquid 
chromatography (nLC) instrument with an all glass µFFE device followed by 
investigating factors which could affect the efficiency of the technique. A new 
µFFE device was designed and fabricated for coupling with nLC. High peak 
capacity separations of tryptic peptides of BSA demonstrated the power of the 
technique. Broadening in temporal and spatial dimensions were investigated 
since peak capacity is calculated using analyte peak width. The observation that 
the adsorption of analytes only affects broadening in the temporal dimension is 
critical for maximizing peak capacity. Finally, the effect of using fluorescent labels 
in 2D nLC × µFFE separations will be demonstrated. The impact of label choice 
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1.1 Separations of Complex Mixtures 
 Over the last several decades significant advancements have been made 
in diagnostics, therapy, microbiology, and biochemistry. A major driving force in 
these advancements is due to the increased research in the fields of genomics, 
proteomics, and metabolomics. Pairing a well resolved separation with a 
sensitive detection strategy is able to provide both the selectivity and limits of 
detection required to analyze a biological sample. However, the high complexity 
of these samples puts a strain on the capabilities of current separation methods. 
Specifically, the traditional one-dimensional (1D) separation platforms routinely 
used are simply overwhelmed by the number of components in these mixtures. 
The following section describes the importance of the omics fields and the 
complexity of the samples, in addition to the current limitations of separation 
methods.  
1.1.1 Omics Fields  
 The study of systems biology can provide key insights into the pathways 
and mechanisms in which living things function. The collective characterization 
and quantification of the molecular interactions that result in the structure, 
function, or dynamics of an organism is referred to as omics. Many of these fields 
have emerged such as genomics, lipidomics, proteomics, metabolomics, and 
even foodomics, referring to the studies of genes, lipids, proteins, metabolites, 
and food and nutrition, respectively. The common challenge facing researchers 
in these fields is the complex, coordinated regulation of many hundreds of 
proteins and genes. The human genome, for example, contains ~30,000 genes.1 
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These genes, however, encode thousands of proteins. An individual human cell 
can contain anywhere from 20,000 to 50,000 proteins. The need for powerful 
separation techniques is amplified by the dynamic range of these proteins, 
ranging from 102-108 copies.1 Often times these samples are subjected to 
shotgun analysis, where the proteins are further broken down into peptides, 
increasing the complexity even more.2 In metabolomics low molecular weight 
(<1,500 Da) compounds resulting from the metabolism of cells and tissues are 
analyzed. Human urine has been estimated to contain ~800 metabolites, while 
4,600 have been identified in human blood.3-5 Though not as complex as the 
genome or proteome, 1D separation methods are very quickly overwhelmed as 
will be described in the next section.  
1.1.2 Traditional 1D Separation Methods 
 Any of the biological samples mentioned clearly require some form of 
separation prior to further analysis. Nucleic acids, such as DNA and RNA, which 
control the expression of genes, act on a slower time scale than protein 
interactions. Quantitative PCR and microarrays have become established 
methods to determine the genomic status of a system, but the need for high-
throughput methods for proteins remains high. Growth in the field of proteomics 
has been limited by the lack of fast, reproducible, and high separation efficiency 
techniques. Compared to DNA, proteins are more complex, being made up of 
more “building blocks”, harder to separate, have a high variability of physical 
properties and functions, and are more difficult to detect.6 
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 Peak capacity is the number of fully resolved peaks which can fit into a 
separation. Current 1D separation methods often fall short of the number of 
compounds in biological samples. (Figure 1.1) 
 
Figure 1.1: Peak capacity in 1D separations A) Ideal separation where all peaks 
are fully resolved at the baseline B) 1D separation where the peak capacity is 
sufficient to fully separate most of the peaks, though some are not fully resolved 
C) 1D separation of a complex sample. The number of peaks overwhelms the 




 1D liquid chromatography (LC) methods typically produce peak capacities 
of around 500 in 30-60 minutes for peptides, while only 200-300 for non-peptide 
mixtures.2 Capillary zone electrophoresis (CZE), which often provides high 
separation efficiencies up to one million theoretical plates per meter7, also only 
produces peak capacities in the 300-500 range for peptides in a one hour 
analysis time.8 These methods simply cannot “fit” the number of components in a 
complex sample across their separation spaces. (Figure 1.1c) Peak capacities 
greater than even 5,000 would be needed to even begin resolving these 
mixtures, which are not achievable in reasonable analysis times (<3 hours). 
1.1.3 2D PAGE in Proteomics 
 Slab gel electrophoresis has been a useful tool in separating biological 
samples over the last several decades and is one of the most common 
techniques used. However, it is severely limited by slow analysis times, limited 
quantitation methods, and high degree of labor. In a 1D format only a few 
analytes can be identified, often with the use of antibody staining.9 By switching 
to a multidimensional platform, many more compounds can be analyzed. 
 Two-dimensional polyacrylamide gel electrophoresis (2D PAGE) is often 
regarded as the gold standard in proteomic separations. First introduced by 
O’Farrell10, 2D PAGE is a powerful separation technique because it separates 
analytes based on multiple properties. (Figure 1.2) First, compounds are 
separated by isoelectric point (pI) using isoelectric focusing (IEF). They are then 
separated according to their molecular weights by rotating the gel 90˚ and 
running sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
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PAGE).1 2D PAGE is able to resolve up to 10,000 proteins, with ~2,000 being 
routine, allowing for its use in the study of genetic variations, cellular 
differentiation, diagnostics, and cancer research. 
 
Figure 1.2: Two-dimensional polyacrylamide gel electrophoresis (2D PAGE) 
Analytes are first separated by pI using isoelectric focusing in the first dimension 
and then separated by molecular weight using PAGE in the second dimension. 
  
 Despite its high resolving power, 2D PAGE is limited by a low dynamic 
range (3-4 orders of magnitude), difficulty in analyzing proteins which are very 







1.2 Two-Dimensional Separations 
 The ability to combine multiple techniques to separate a sample by 
several properties can dramatically improve the quality of a separation compared 
to a 1D technique alone. As seen with 2D PAGE, very large numbers of 
constituents can be separated when pairing techniques. Both separations 
occurring in 2D PAGE are examples of separations in space, where components 
are allowed to migrate over a physical separation space for a fixed amount of 
time.11 Due to the drawbacks of 2D PAGE, much research has been placed in 
coupling other 1D techniques, such as LC, CZE, and gas chromatography (GC). 
These differ from 2D PAGE in that they are all separations in time, meaning there 
is a fixed migration distance (ex. column length) and sample components elute at 
different times based on retention.11 These column based platforms can either be 
on-line or off-line. Off-line methods collect fractions from the first dimension and 
analyze them separately with the second dimension. Though this method allows 
for sample manipulation and independent optimization of both dimensions, the 
tradeoff is significant increases in analysis times.  
 
Figure 1.3: Diagram of an on-line 2D separation. The first dimension is sampled 
through an interface and injections are done onto a second separation. In the 
case of a comprehensive separation the second dimension must be run and fully 




On-line methods use an interface to directly couple the first and second 
dimensions. (Figure 1.3) This coupling often results in much faster separations, 
however optimization is not as straightforward.  
1.2.1  Comprehensive On-line 2D Methods 
 To fully understand the components of a complex mixture, the entirety of 
the first separation should be subjected to analysis by the second (i.e. be 
comprehensive). Erni and Frei first used comprehensive 2DLC to separate  
senna glycosides using size-exclusion chromatography (SEC) and RPLC.12 Peak 
capacity was limited, however, due to only seven fractions being taken from the 
first dimension. For protein analysis Bushey and Jorgenson were able to achieve 
a peak capacity of 130 for a 6 hour comprehensive separation.13 Since then, 
many combinations of 1D methods have been used to increase peak capacity 
and the rate of peak capacity production including LC×LC13-15, GC×GC16-18, 
LC×GC19, 20, LC×CE15, 21, 22, and CE×CE.23-25 
 One of the more powerful uses of LCxLC has been multidimensional 
protein identification technology (MudPIT). In MudPIT, a microcapillary is packed 
with both strong cation exchange (SCX) and reversed phase (RP) materials.26-30 
Peak capacities up to 3,200 have been reported, though long analysis times of 
up to 10 hours were needed.15 The peak capacity of LCxCE systems has been 
shown to be as high as 20,000 in 5 hours.31 Using microchip CE as a second 
dimension to HPLC, Yang et al. were able to achieve a peak capacity of 1,000 in 
around 1 hour.22 Using a microfluidic device for MEKCxCE, Ramsey et al. were 
able to produce a peak capacity of 4,200 in ~15 minutes.32 Using high 
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temperatures and short second dimension columns, peak capacities of 1,200 
were obtained in 20 minutes using SCX for the first dimension and RPLC for the 
second.33, 34 These hyphenated techniques are quickly approaching peak 
capacities high enough to handle complex samples. However, adequate 
sampling of the first dimension and orthogonality between the methods must also 
be taken into consideration.  
1.2.2 Peak Capacity 
 Peak capacity was originally defined by Giddings as the maximum number 
of peaks that can be separated on a given column35 (i.e. the number of equally 
spaced analyte peaks which could fit across the separation window). (Figure 
1.1a) Typically, peaks are assumed to be equally spaced in the separation 
window. In the case of gradient elution RPLC, the separation window is defined 
by the gradient start time and the end of the gradient run. Karger et al.36 
introduced the multiplicative nature of 2D peak capacities, and this idea was later 
elaborated on by Guiochon37 and Giddings35 as: 
𝑛𝑐,2𝐷 = 𝑛𝑐
1 𝑛𝑐
2   (1.1) 
where the peak capacity of a 2D separation (𝑛𝑐,2𝐷) approaches the product of the 
peak capacities from the first ( 𝑛𝑐
1 ) and second ( 𝑛𝑐
2 ) dimensions. Since it’s much 
faster to generate a peak capacity of n twice, rather than n2 once, 2D separations 
appear to have a distinct advantage over their 1D counterparts.10 For example, if 
a peak capacity of 100 were desired for a given separation, a peak capacity of 




Figure 1.4: Probability of separating a mixture of sample components (m) for 
peak capacities (n) of 100, 1000, and 5000 (eq. 1.2 from reference 38) 
  
 Before going into the experimental application of this increased peak 
capacity, the relationship between peak capacity and actual chromatographic 
peaks should be addressed. Martin et al. used peak overlap analysis to describe 
the probability that all sample components will be resolved for a given peak 
capacity, n, and a given number of sample components, m.38  
𝑃𝑚,𝑛(𝑚) = (1 −
𝑚−𝑛
𝑛−1
)2  (1.2) 
The dramatic decrease in probability of separation can be seen as the samples 
become even slightly more complex. (Figure 1.4) A peak capacity of 100 can 
only separate a 10 component mixture 50% of the time. Once the sample has 
greater than 15 components, the probability drops below 10%. Even with peak 
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capacities of 1,000 or 5,000, sample mixtures containing more than 100 
compounds are almost impossible to fully resolve without increasing the peak 
capacity. 
 
Figure 1.5: Peak capacity required to separate a sample of a set number of 
components (m) with probabilities of 10%, 50%, and 95% chance of complete 
separation (eq. 1.3) 
 





   (1.3) 
 The peak capacity required (nmin) to fully separate an m component 
mixture with Px probability is given by equation 1.3. As the number of 
components increases from 10 to 100 the required peak capacity increases from 
65 to 13,500 at the 50% probability level. (Figure 1.5) Even if a 10% probability 
would be tolerable, a 1,000 component mixture would require a peak capacity of 
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over 400,000! Both models in Figures 1.4 and 1.5 assume randomly distributed 
peak positions and uniform peak widths. With optimization, better separations 
than these models predict can be achieved, however they stress the importance 
on maximizing peak capacity. 
 Another advantage to high peak capacities can be seen in Figure 1.5 for 
the 95% probability curve. For relatively small samples (m < 20) the peak 
capacity required is around 5,500. Though this peak capacity is not readily 
achievable using a 1D separation, 2D techniques are quickly approaching this 
level. It becomes clear that high peak capacity separations have an advantage 
over their 1D counterpart. An exceptional 1D separation with a peak capacity of 
500 could only separate a mixture of 5 or 6 compounds with 95% probability. 
Though optimization could be done to better the separation, the peak capacities 
generated in multidimensional separations would allow for separation without 
optimization. 
1.2.3 Under Sampling 
 As mentioned in Section 1.2.1, on-line 2D separation methods collect 
fractions as they elute off of the first dimension and then are directly injected onto 
the second dimension. In order to achieve the peak capacity described in eq. 1.1, 
no resolution generated in the first dimension must be lost in the second 
dimension. This loss is often caused by the under sampling of the first dimension 
or remixing at the interface between dimensions. The sampling rate of a first 
dimension peak is defined as the number of fractions which are taken across the 
peak width. Murphy et al. originally proposed a sampling rate of 3-4 times across 
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the 8σ peak width.39 Often, in 2DLC, the second dimension separation is unable 
to sample this quickly for shorter first dimension analysis times, resulting in 
deleterious losses in peak capacity simply by not sampling fast enough. Davis, 
Stoll, and Carr developed a metric, β, to account for under sampling and how the 
ideal peak capacity is reduced. The amount of reduction, or fraction of 1nc 






   (1.4) 
 
𝛽 = √1 + 𝛼 × (
𝑡𝑠
𝜔1
)    (1.5) 
 
The degree to which a peak is under sampled is proportional to the ratio of the 
second dimension cycle time, ts, and the 4σ width of a first dimension peak, 
1ω. 
The under sampling coefficient, α, was determined to be 3.35 for separations of 
random multi-component systems (random retention times and peak heights in 
both dimensions).41 The value of α was determined for a resolution of 1 between 
adjacent peaks. Even faster first dimension sampling rates would be required if 
higher resolution is needed to separate two or more components.  
 Figure 1.6 demonstrates the loss of peak capacity due to the under 
sampling of the first dimension. If a first dimension separation generating 
100,000 theoretical plates in 60 minutes is chosen, it is estimated 62% of the 
peak capacity is lost, even if the second dimension cycle time is only 1 minute. 
On an LC time scale, this rate is pushing the limits of speed at which a gradient 
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can be run and the column re-equilibrated. The fastest LC x LC cycle times 
reported are between 12-21 seconds.14, 33, 34 For the same 60 minute separation, 
 
Figure 1.6: Fraction of peak capacity retained in the first dimension (1/β) vs. 
second dimension cycle time (ts) for first dimension separation times of 5, 15, 30, 
60, and 120 minutes assuming a first dimension efficiency of 100,000 theoretical 
plates. 
  
these rates would still result in ~20% of the peak capacity lost due to under 
sampling. Going to a shorter first dimension separation of 15 minutes would 
result in 70% of the peak capacity being lost. The need to adequately sample the 
first dimension is often why 2D separations have long analysis times. It’s 
important to emphasis also that any reductions in second dimension cycle time 
generally result in a reduced second dimension peak capacity. The result 
becomes an optimum sampling time for each set of first dimension separation 




 In addition to correcting for the under sampling of the first dimension, the 
separation mechanisms must be orthogonal, or uncorrelated. The original use of 
orthogonality comes from 2D thin layer chromatography (TLC) or 2D PAGE, 
where the separations in the first and second dimensions are performed 90˚ to 
each other.35  
 Orthogonality represents how efficiently the separation space is utilized. 
There are two factors, proposed by Giddings, which determine the orthogonality 
of a 2D separation. The first is the separation dimensionality, which refers to the 
number of separation mechanisms used in the system (ex. the number of 
columns coupled together in 2DLC or 2DGC). The other is the dimensionality of 
the sample. Giddings proposed a sample can be characterized by the number of 
independent variables needed to identify the components of the sample (ex. size, 
charge, electrophoretic mobility, hydrophobicity, etc.).44 If the sample were to not 
have enough complexity, the addition of more separation dimensions would offer 
minimal gains in peak capacity. For a separation using two-dimensions, for 
example, the sample must have a dimensionality of 2 or more to observe any 
degree of orthogonality.  
 There have been many methods for determining the orthogonality of both 
separation modes and samples including correlation coefficients45, 46, fractal 
dimensionality47, geometric approaches such as fan area48, counting peaks49, 
and modified forms of box counting.50-52 Rutan et al. have demonstrated the use 
of metrics based on ecological home range calculations for determining the 
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fraction coverage (ƒ) of peaks in a 2D separation space.53 In particular, they 
found the minimum convex hull method to have advantages over previously 
mentioned methods.  
 
Figure 1.7: Minimum convex hull plots for 2D separations A) A separation where 
the separation modes are not orthogonal. No additional gains in resolution occur 
between the first and second dimensions B) A separation where the modes are 
fairly orthogonal and the peaks are spread out over a larger fraction of the 
separation space. 
 
 The minimum convex hull defines the usable, or accessible, separation 
space by drawing the smallest convex polygon (i.e. all interior angles are less 
than or equal to 180˚) around the outermost peaks of the separation. This 
approach is simple, lacks adjustable parameters, and can be calculated using a 
standard function in Matlab. Figure 1.7 demonstrates the use of the minimum 
convex hull for both separations of low (Figure 1.7a) and high (Figure 1.7b) 
degrees of orthogonality. Accounting for ƒ modifies equation eq. 1.1 into eq. 1.6 
to give the effective 2D peak capacity of a separation. Under sampling manifests 






× 𝑓     (1.6) 
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 However, often times ƒ is not reported or taken into account when 
calculating nc,2D therefore both corrected and uncorrected values will be given 
when making comparisons in later sections.   
 
1.3 Micro Free Flow Electrophoresis (µFFE) 
 Free flow electrophoresis (FFE) has been used over the last five decades 
primarily for the isolation and fractionation of cells, organelles, and protein 
mixtures.54 With the increased interest in the omics fields, the applications of FFE 
as an analytical tool have been explored. As with many of the major analytical 
separation techniques such as LC, CE, or field flow fractionation (FFF) the 
miniaturization of FFE to a microfluidic format has resulted in increased 
performance and applications.  
1.3.1 Free Flow Electrophoresis (FFE) 
 Free Flow electrophoresis was first introduced by Barrolier et al. in 
195855and Hannig in 1961.56 In FFE, analytes are continuously driven by 
pressure flow through a separation chamber. An electric field is applied 
perpendicular to this flow and analytes are deflected into distinct streams based 




Figure 1.8: Operating principle of free flow electrophoresis (FFE). Sample is 
introduced to the top of a planar separation channel and driven by buffer flow. An 
electric field is applied perpendicular to the flow and analytes separate into bands 
based on their mobility. Fractions can then be collected at the end of the 
separation chamber. 
  
 Because the separation occurs in a different direction than the bulk flow, 
sample injection, separation, and collection take place continuously, unlike 
discrete injections used in traditional CE. The continuous nature of FFE has 
made it a common tool in protein and DNA purifications using separation modes 
such as free flow zone electrophoresis (FFZE)57, free flow isoelectric focusing 
(FFIEF)58, 59, and free flow isotachophoresis (FFITP).60-62  
 The dimensions and volumes used in FFE devices result in a relatively 
high cross-sectional area and low surface-area-to-volume ratio, leading to poor 
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heat dissipation. Joule heating is often observed as field strengths begin to go 
above 100 V/cm.54, 63 The miniaturization of devices yields higher surface-area-
to-volume ratios, decreased residence times, less sample and reagent 
requirements, and increased sensitivity.64, 65 These advantages make FFE a 
prime technique to integrate into a microfluidic platform in order to eliminate 
Joule heating within the separation channel and find applications in micro-
preparative separations.  
1.3.2 Development and Fabrication of µFFE devices 
 Raymond et al. were the first to miniaturize FFE in 199466 using micro 
machined channels in silicon and further developed the technique in 1996.67 
They were able to show that the smaller separation volumes dissipated heat 
more rapidly, effectively removing Joule heating as a major source of band 
broadening. The main drawback to the use of silicon for the device, however, 
was the low field strengths (<50 V/cm) that could be applied due to the formation 
of electrolysis bubbles. These bubbles enter the separation channel and can 
distort the flow profile. Additionally, silicon has a breakdown voltage between 
100-200V, limiting the maximum field strength even if bubbles weren’t present.66 
Since then µFFE devices have been fabricated in polydimethylsiloxane68-71, 
poly(methyl methacrylate) (PMMA)72, biaxially-oriented polyethylene 
terephthalate (Mylar™)73, and glass74-80. These materials allow for higher 




 The generation of electrolysis bubbles still remains a limitation to the 
strength of the electric field which is applied. Preparative FFE devices use ion-
exchange membranes to isolate the electrodes from the separation. These 
membranes are difficult to implement in a microfluidic format due to the small 
feature sizes, often 100 µm or less. Methods for either isolating or reducing 
electrolysis bubbles in µFFE devices have included channel arrays66, multiple 
channel depth81, suppression via redox couples82, buffer additives71, 83, 84, 
partitioning bars69, glass bridges76, ion permeable salt-bridges79, functionalized 
gels70, and hydrogel membranes.78 A combination of multiple channel depth and 
buffer additives has been used in this work and has shown stream stability up to 





Figure 1.9: Fabrication scheme developed for glass µFFE devices. Borofloat® 
glass (white), amorphous silicon (gray), S1813 photoresist (red), titanium (blue), 
and gold (yellow). 
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 Device fabrication in glass follows the process described in Figure 1.9. A 
borosilicate glass wafer is first protected by depositing a layer of amorphous 
silicon (aSi) using plasma enhanced chemical vapor deposition (PECVD). 
Standard photolithography and wet etching procedures are used to define and 
etch features into the glass. Photolithography and wet etching can be repeated to 
define features with multiple depths. The remaining aSi is then removed using 
reactive ion etching (RIE). Electrodes are patterned onto the devices by first 
depositing a layer of Ti and Au by electron beam evaporation and then using 
photolithography and wet etching to remove the unwanted metal. Access holes 
for fluidic and electrode connections are then drilled into a second wafer. This 
wafer may or may not already have features etched depending on the design of 
the device. The wafers are then anodically bonded together by depositing a thin 
layer of aSi to one wafer and applying a high voltage under vacuum and high 
heat. A completed device can be seen in Figure 1.10. More detailed descriptions 
of this process can be found in later experimental sections and group 







Figure 1.10: Completed µFFE device (1) buffer inlets (2) sample inlet capillary 
(3) electrodes (4) buffer outlets. 
 
 Detection schemes for microfluidic devices have utilized optical methods 
(fluorescence78, 83, 85, UV86, IR spectroscopy87, 88, surface enhanced Raman 
scattering (SERS))89, 90, electrical methods (conductivity91, charge field effect92, 
impedance93, changes in potential94, cyclic voltammetry95), NMR spectroscopy96, 
and mass spectrometry.80, 97 Detection of analytes in microfluidic devices is 
limited by the small volumes and short path lengths stemming from their small 
feature sizes. On-chip detection in µFFE offers a unique challenge because 
sensing across the entire separation channel, rather than a fixed point, is 
required. Schemes utilizing either a scanning point-source detector66, 67, 72 or 
continuously imaging a broader area using a microscope75, 78, 79, 81, 83, 85 have 
been employed, though the use of point detectors requires accurate and precise 
control of the spatial movement of the device. To improve limits of detection, 
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laser-induced fluorescence (LIF) is commonly used. In the work presented, a 488 
nm laser is expanded into a line and directed across the separation channel of 
the µFFE device. A charge-coupled device (CCD) camera is positioned on top of 
an optical microscope above the µFFE chip. The CCD camera then converts the 
light intensity passing through filter cubes into a measurable signal. Further 
impacts of the use of LIF will be discussed in Chapter 4. 
1.3.3 Modes of Operation and Applications 
 Much like its preparative counterpart, µFFE can be run in a variety of 
electrophoretic modes. Interchanging between µFFZE66, 67, 75, 85, µFFIEF71, 78, 98, 
and µFFITP99 merely requires a change in buffer composition, such as the 
addition of ampholytes in the case of IEF. To date, separations of fluorescent 
dyes71, 75, amino acids66, 69, 71, peptides85, proteins67, 72, 76, 98, 100, 101,     
organelles70, 77, 102, and whole cells70 have been reported. 
 Most of these applications, however, have been proof-of-concept 
experiments to compare and improve chip design in addition to improvements in 
resolution. The design improvements and methods of improving stream stability 
have generated a few practical applications of µFFE. Kostal et al. were able to 
use µFFE for continuous separations of mitochondria from rat myoblasts in less 
than 30 seconds. Compared to preparative FFE, the micro devices used      
~100-fold less sample, ~10-fold less buffer, and required a 15-fold lower electric 
field. In comparison to CE, µFFE was shown to have shorter analysis times and 
use less separation voltage. Additionally µFFE  offers the potential to collect and 
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further characterize organelles, making it an attractive tool for micro total analysis 
systems (µTAS).102  
 Fonslow and Bowser developed the use of gradient µFFE to rapidly 
optimize buffer conditions for the separation of primary amines. A gradient of 
hydroxypropyl-β-cyclodextrin was applied over a 5 minute window allowing for 60 
sets of buffer compositions to be tested. In comparison, to test even 15 sets of 
conditions using CE required 4 hours.103 Gradient µFFE was also used by 
Turgeon et al. to investigate the equilibria of DNA aptamers with their protein 
targets. The continuous nature of µFFE allowed for 300 discrete concentrations 
of protein to be observed in 5 minutes, significantly faster than affinity CE assays. 
Another advantage of the µFFE system was the ability to see transitions of 
stoichiometries over a distribution of protein target concentration, revealing 
additional information about the dynamics of the complex.104 µFFE was also used 
to isolate DNA aptamers for human immunoglobulin E. The continuous nature 
was again shown to be an advantage of traditional CE, allowing for a 300-fold 
improvement in library size screened. Four rounds of selection were able to be 
performed in only four days, with only one round being required to generate 
aptamers with low nM dissociation constants.105 Using inkjet-printed sensors, 
Herzog et al. were able to fabricate a µFFIEF device which could be used for 
rapid pI determination. The applicability to use this method as part of a µTAS 





1.4 µFFE as a Second Dimension  
 To date, FFE in both preparative and microfluidic scale devices have only 
been used as pre-fractionation tools in off-line multidimensional separations. 
Moritz et al. used a FFIEF device to separate proteins into 96 fractions, each 
then subjected to a 6 minute RPLC gradient. Though a total peak capacity was 
calculated to be 6,720, the near 10 hour separation only results in a peak 
capacity generation rate of ~12 peaks/min.106 Another multidimensional scheme 
was done using FFIEF followed by SCX and microcapillary RPLC. The addition 
of FFIEF was shown to produce 5-fold more protein identifications and 6-fold 
more peptide identifications. Though low abundance proteins typically hard to 
detect with 2D PAGE were able to be identified, the total analysis time for the 
system was almost 4 days.107 The reduced sample requirements of µFFE and 
the continuous separation ability suggest that it could be utilized more effectively 
as a second dimension.  
 The cycle time of the second dimension in on-line comprehensive 2D 
separations has already been shown to be crucial in preserving the efficiency of 
the first dimension separation. (Section 1.1.6) As shown in Figure 1.6, cycle 
times even as fast as 10-20 seconds are not sufficient once analysis times 
become less than 30 minutes. µFFE offers a unique advantage since the 
separation occurs in space rather than time. The µFFE device essentially then 
acts as a chemically selective detector sampling infinitely fast. The only limitation 
on the cycle time is the time required to detect an analyte. In this work, a CCD 
camera is used for detection. Common exposure times to detect low nanomolar 
27 
 
concentrations of fluorescent dyes range from 100-250 msec.75, 81, 85, 103, 108 The 
utility of this sampling rate, and the advantage µFFE has over traditional LC as a 
second dimension, can be seen if we compare the two methods using a first 
dimension peak width which is very narrow. The peak width of a peptide from a 
BSA tryptic digest was reported to be 48 seconds.22 Using this width for a first 
dimension peak, a second dimension LC gradient of 12 seconds would result in 4 
samples taken per peak, and ~17% of the peak capacity from the first dimension 
would be lost due to under sampling (eq. 1.4 and 1.5). In comparison, a camera 
exposure time of 100 msec using µFFE as a second dimension would generate 
480 samples across the same peak, resulting in less than 0.5% of the first 
dimension peak capacity being lost. A more significant example can be seen if 
the peak width from the second dimension was used. Microchip CE peaks for the 
BSA tryptic digest were shown to be 0.65 seconds.22 In the case of LC, ~90% of 
the peak capacity would be lost negating almost all of the separation achieved in 
the original separation. Using µFFE would still retain over 80% of the original 
peak capacity. The ability of µFFE to rapidly sample peaks gives it a distinct 
advantage over other separation methods, especially when peaks become 
narrow, giving it a wider range of use. 
1.4.1 µFFE Interface 
 In order to fully maintain the peak capacity, there must also be no mixing 
of the sample stream when connecting the first dimension to the microfluidic chip. 
If the sample stream were to encounter any significant dead volumes, the mixing 
of analytes could occur, resulting in a loss in resolution. 
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 In 2D separations using multiple columns, complicated valve systems are 
needed which are precisely controlled to keep injections timed.14, 16 Conversely, 
there are commercially available products are made to make fluidic connections  
to microfluidic devices. IDEX Nanoports™ used in this work are placed over 
access holes and allow for a variety of tubing and capillary sizes to be 
connected. However, a dead space is created equal to the size of the hole in the  




 This volume has minimal impact when a sample is being continuously 
injected for monitoring experiments; however this space is unsuitable for 
maintaining the resolution of a first dimension peak. Bings et al. made capillary 
connections to microfluidic devices by drilling into the edge of the device with a 
Figure 1.11: Diagram of a connection to a microfluidic device using a NanoPort™. 




flat bottomed drill bit. They were able to show ~98% of the theoretical plates of a 
peak were maintained through the interface.109 However, due to the length of the 
channels and the need for precise alignment this method can not easily be 
implemented in µFFE. Fluidic connections have also been made using custom 
machined parts,97 but the need for new, simple, strategies still remains. A new 
strategy for making a zero dead volume connection to a µFFE device will be 
discussed in Chapter 2. 
1.4.2 Broadening in µFFE 
 The width of an analyte band in µFFE will limit the 2D peak capacity 
achievable since the separation space is fixed to the width of the device. The 
total variance of an analyte band (𝜎𝑡𝑜𝑡𝑎𝑙
2 ) is the sum of all of the factors that 
contribute to peak broadening: 
𝜎𝑡𝑜𝑡𝑎𝑙




2    (1.7) 
where 𝜎𝑖𝑛𝑗
2  is the broadening due to injection, 𝜎𝐷
2 is the broadening due to 
diffusion, 𝜎𝐻𝐷
2  is the hydrodynamic broadening contribution, and 𝜎𝐸𝑀𝐷
2  is the 
electromigration dispersion contribution.108 







   (1.8) 
where 𝑤𝑖𝑛𝑗
2  is the width of the injected analyte stream.108 The variance from this 
contribution is lowered as the width of the injection is reduced. The determining 
factor for the width of the sample band is dependent on hydrodynamic focusing. 
Hydrodynamic focusing will occur if the incoming stream is flowing at linear 
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velocities lower than the bulk flow velocity.79 The ratio of linear flow rates 
between sample injection and buffer flow rate can be modified to narrow or widen 
a band. 
 Broadening due to diffusion can be expressed by eq 1.9: 
𝜎𝐷
2 = 2𝐷𝑡 =  
2𝐷𝐿
𝑣
  (1.9) 
where D is the diffusion coefficient of the analyte, t is the analyte residence time 
between injection and detection, L is the length of the separation channel, and 𝑣 
is the flow velocity. From eq 1.9, it can be seen that a shorter residence time will 
minimize this contribution which can be achieved through higher flow rates. 
 Hydrodynamic broadening is due to the pressure-driven parabolic flow 





   (1.10) 
Broadening by this factor is related to the height of the separation channel (ℎ), 
the migration distance (𝑑), 𝑣, D, and L. This “cresent effect” has been described 
by Fonslow and Bowser and variance due to this source can be minimized by 
having small channel heights (common for microfluidic devices) and lower linear 
velocities to narrow the parabolic flow profile.108 
 Electromigration dispersion (𝜎𝐸𝑀𝐷
2 ) occurs when the buffer composition 
across the area where the electric field is applied is not constant, leading to 
areas of varying conductivities in the separation channel. This variation results in 
broadening because analytes will travel at different speeds through the different 
buffer compositions. In continuous µFFE separations, this source is not 
significant because the sample buffer conductivity can easily be matched to the 
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FFE electrolyte buffer. In 2D hyphenated systems, however, the mobile phase 
from the first dimension may not match conductivity with the electrolyte buffer, 
leading to potential broadening or focusing of peaks.110, 111 
 Substituting eq 1.8,1.9, and 1.10 into eq 1.7 gives the total variance of an 
analyte band (assuming no contribution from electromigration dispersion, as is 












   (1.11) 
A complex dependency between flow velocity and analyte migration distance (a 
function of applied voltage and flow velocity) on 𝜎𝑡𝑜𝑡𝑎𝑙
2  can be observed. Fonslow 
et al. further rearranged eq 1.11 to give an optimum flow velocity of108: 
𝑣𝑜𝑝𝑡 =  
√210𝐷𝐿
ℎ𝑑
  (1.12) 
Having this in-depth understanding of broadening mechanisms is critical for 
maximizing peak capacity in the µFFE dimension. 
1.4.3 Orthogonality and Separation Modes 
 µFFE also can be very versatile as a second dimension due to the variety 
of electrophoretic separation modes it can operate under. As mentioned in 
section 1.3.2, µFFE can be employed using zone electrophoresis, micellar 
electrokinetic chromatography (MEKC), IEF, and ITP. In zone electrophoresis, 
components are separated into bands based on their net electrophoretic 
mobilities. MEKC incorporates a surfactant above its critical micelle concentration 
(CMC) to act as a pseudo-stationary phase. This phase allows for the separation 
of neutral species, which are normally difficult to separate by zone 
electrophoresis. IEF utilizes a pH gradient to separate analytes based on their 
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individual pI’s. By applying an electric field across this gradient, molecules 
migrate until they are electrically neutral. In µFFE, a gradient is generally 
established by using pre-sorted ampholytes in the separation buffer.78  ITP is 
another focusing technique which introduces a sample between a leading and 
trailing electrolyte. Analytes focus into zones in order to match conductivities of 
the leading and trailing buffers.99 The number of modes available can provide 
orthogonal separation mechanisms to a range of first dimension techniques such 
















1.5 Scope of Thesis 
 The increasingly complex samples seen in biomedical and environmental 
research have overwhelmed the ability of traditional one-dimensional separations 
to effectively analyze them. Even recently developed comprehensive on-line 
methods do not have sufficient peak capacity. Oftentimes the theoretically 
attainable peak capacity is not achieved due to under sampling of the first 
dimension or lack of orthogonality between separation modes. Chapter 2 will 
describe the development of a novel 2D separation platform coupling nano-liquid 
chromatography (nLC) with µFFE. A zero dead volume interface will be 
presented and shown to provide a suitable connection to the microfluidic chip. 
High peak capacities generated will show the potential of this technique. With the 
utility of the nLC × µFFE platform demonstrated, Chapter 3 will take a closer look 
at the differences in broadening between the temporal and spatial dimensions. 
The impact of surface adsorption will be explored to better understand how to 
maximize peak capacity in each dimension. Chapter 4 will explore the use of 
fluorescent labels in µFFE. The use of LIF requires the sample to be either 
natively fluorescent, or be labeled with a fluorogenic reagent. The impacts on 
sample dimensionality and overall orthogonality will be assessed. Lastly, Chapter 
5 will detail the work accomplished up to this point, and provide a range of future 
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 The throughput capabilities of two-dimensional (2D) separations is largely 
impacted by peak capacity lost due to the under sampling of first dimension 
peaks by the second dimension. The continuous nature of micro free flow 
electrophoresis (µFFE) offers a unique solution to the under sampling challenge. 
In this work nano-liquid chromatography (nLC) is coupled directly to a µFFE 
device to be used as the second dimension. Since µFFE is a continuous 
technique where separation occurs perpendicular to the flow, no complicated 
injection was necessary to interface the two techniques. The flow rates of nLC 
(50 – 500 nL/min) are also within the range of current µFFE devices               
(100 – 500 nl/min) eliminating the need for any flow modulation. A side-on 
interface was designed and fabricated into an all glass microfluidic device to 
minimize the dead volume in the nLC × µFFE interface, eliminating the potential 
for re-mixing, which can introduce band broadening.  A Chromeo™ P503 labelled 
tryptic digest of BSA was used as a complex mixture to assess the performance 
of the system. Total 2D peak capacities as high as 2,352 were observed in a 10 
minute separation window leading to a peak capacity production rate of 105 
peaks/min, nearly double the highest rates reported for on-line LC × LC. After 
accounting for the fraction of the separation space occupied by peaks, the 
adjusted 2D peak capacity was determined to be 776 demonstrating the potential 






 Chromatography and electrophoresis separations have been powerful 
tools in the analysis of mixtures. Coupling a well resolved separation with a 
sensitive detection strategy provides unmatched selectivity and limits of 
detection. Unfortunately, increasingly complex mixtures are being encountered in 
modern biomedical and environmental research which often overwhelms the 
peak capacity achievable using traditional one-dimensional separations. The 
pairing of two separation techniques to generate a two-dimensional (2D) 
separation provides an attractive approach for handling these mixtures by 
substantially increasing peak capacity. As described by Giddings, the ideal peak 
capacity of a 2D separation (nc,2D) is the product of the peak capacities from the 
first (1nc) and second (
2nc) dimension separations (eq 1.1).
35 
 2D gel electrophoresis is an example of a well-executed 2D separation 
and has been shown to be very powerful in the separations of protein   
mixtures.1, 10 Online 2D separations, which capture fractions as they elute off of a 
first dimension and are then directly injected onto the second, have been 
developed to overcome some of the limitations of 2DGE such as analysis time 
and sample range.13, 21 Often times these hyphenated methods do not satisfy the 
necessary criteria for achieving the ideal peak capacity. To achieve the ideal 2D 
peak capacity two criteria must be met: 1) the separation mechanisms of the two 
dimensions must be orthogonal and 2) no remixing or under sampling at the 
interface between the two separations occurs.35 A modified equation accounting 
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for non-ideal orthogonality and under sampling was developed by Davis, Stoll, 
and Carr (see equation 1.6).40 
 The fractional coverage (ƒ) accounts for losses in peak capacity due to the 
correlations in the separation modes chosen. In order to attain the maximum 2D 
peak capacity, the separation mechanisms must be completely orthogonal and 
make the entire separation space accessible to be occupied by an analyte 
peak.112 Giddings proposed nc,2D could range from the maximum ideal case to a 
minimum of 1nc, where the second dimension elution time is fully correlated to the 
first dimension elution time.35 Fraction coverage and orthogonality have been 
calculated using a number of methods.50, 53 Rutan et al. have shown the merits of 
the minimum convex hull method for estimating (ƒ) due to its simplicity and ease 
of calculation.53 
 While losses in peak capacity due to orthogonality can be addressed with 
the appropriate choice of separation conditions, under sampling has remained a 
major limitation to the potential separation power of 2D separations.  In many 
cases the second dimension separation is unable to sample the first dimension 
peaks fast enough, giving rise to substantial losses (>20%) of peak capacity at 
the interface. Davis et al. were able to quantify this loss in peak capacity due to 
under sampling (eq 1.4 and 1.5).40  
 Micro free flow electrophoresis (µFFE) offers a unique solution to the 
under sampling limitations found in current 2D separations. FFE is a separation 
technique where samples are introduced as a continuous stream at the entrance 
of a planar separation chamber. As the analytes are carried in a pressure driven 
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flow through the channel, an electric field is applied laterally, deflecting analyte 
streams according to their electrophoretic mobilities. Since devices were first 
miniaturized by Raymond et al.66 µFFE devices have been fabricated in a variety 
materials such as polydimethylsiloxane68-71 (PDMS), poly(methyl methacrylate) 
(PMMA)72, biaxially-oriented polyethylene terephthalate (Mylar™)73, and    
glass74-80 for the separations of fluorescent dyes71, 75, amino acids66, 69, 71,          
proteins67, 72, 76, 98, 100, 101, organelles70, 77, 102, and whole cells70 
 To date, FFE, on either a preparative or micro scale, has only been used 
in 2D separations as a first dimension pre-fractionation tool.106, 107 Although peak 
capacities greater than 5,000 were observed, excessively large analysis times 
were required due to the off-line analysis of FFE fractions collected. The reduced 
sample requirements and continuous nature of µFFE suggests an alternative 
approach: direct coupling to µFFE as a second dimension separation. Because 
µFFE performs a continuous separation of the incoming sample stream, the 
sampling time becomes the time required to collect an image for detection. 
Exposure times of 100-250 msec are typical for previously reported µFFE 
assays.75, 81, 103 Cycle times of this low magnitude would allow significant 
reductions in the analysis time of 2D separations without incurring the under 







2.3.1 Chemicals and Reagents 
 All solutions were made using deionized water (18.3 MΩ, Milli-Q; Millipore, 
Bedford, MA) and filtered with a 0.22 μm nitrocellulose membrane filter (Fisher 
Scientific, Fairlawn, NJ) unless otherwise described. µFFE separation buffer 
contained 300 μM Triton X-100, 8M Urea, and 50 mM MES hydrate, all of which 
were purchased from Sigma-Aldrich (St. Louis, MO). The pH of the solution was 
adjusted to 5.56. Poly(ethylene oxide) (PEO) was dissolved in water to 0.2% by 
mass with 0.1 M HCl at 95 ˚C for 2 h while stirring. Eluents for nLC were 
prepared using LC-MS grade water and LC-MS grade ACN, both purchased from 
J.T. Baker (Phillipsburg, NJ). Trifluoroacetic acid (TFA) was purchased from 
Sigma-Aldrich. Stock solutions of rhodamine 123 (Sigma-Aldrich) and rhodamine 
110 chloride (Sigma-Aldrich) were prepared at concentrations of 1.5 mg/mL and 
1.6 mg/mL, respectively, in 190 proof ethanol (Fisher Scientific). A 10 mM 
NaHCO3 solution (Mallinkrodt, Paris, KY) in water and 10 mg/mL Chromeo™ 
P503 (Active Motif, Carlsbad, CA) solution in DMSO (Sigma-Aldrich) were used 
to label 1 nmol of a MassPREP™ BSA digestion standard purchased from 
Waters Corp. (Milford, MA). To perform this labeling reaction, 490 μL of NaHCO3 
buffer was added to the BSA standard and vortexed for 5 minutes. Next, 10 μL of 
the Chromeo™ P503 dye solution was added and vortexed for another 10 
minutes. The vial was allowed to incubate at 25 ˚C for 3 hours before any 
separations were performed. The labeled BSA digest and Chromeo™ P503 
solutions were stored at 0 ˚C when not in use. Piranha solution (2:1 H2SO4:H2O2) 
40 
 
(Ashland Chemical, Dublin, OH) was used to clean glass wafers and etch Ti. GE-
6 (Acton Technologies, Inc., Pittston, PA) was used to etch Au. Concentrated HF 
(49%) (Ashland Chemical) was used to etch glass wafers. Silver conductive 
epoxy (MG Chemicals, Surrey, BC, Canada) was used to make electrical 
connections to the μFFE device. Crystalbond™ 509 (SPI Supplies, West 
Chester, PA) was used to fix fused silica capillaries in the etched capillary 
channel. 
2.3.2 Device Design and Fabrication 
 
Figure 2.1: CAD drawings for the masks used to make µFFE devices. A) 
capillary channel B) electrode channels C) separation channel D) electrodes. 
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 Figure 2.1 shows the masks used to fabricate the µFFE device used to 
interface with nLC.  μFFE fabrication followed a similar procedure to those 
previously reported.75, 81, 83, 108 Briefly, an 85 μm capillary channel was etched into 
two 1.1mm borofloat® glass wafers (Precision Glass & Optics, Santa Ana, CA) 
using standard photolithography techniques. A second photolithography step was 
performed, etching 30 μm deep electrode channels. Finally, a third 
photolithography step etched the remaining features to 10 μm. The end result 
was two mirror image wafers with a 125 μm deep capillary channel (~250 μm 
wide), 40 μm deep electrode channels, and a 10 μm deep × 1 cm wide × 2.5 cm 
long separation channel. To one of the wafers, a 150 nm thick layer of Ti was 
deposited using a Temescal electron beam evaporator, followed by a 150 nm 
thick layer of Au. A photolithography step was performed to remove unwanted Ti 
and Au to pattern the electrodes.  Access holes (1 mm) were drilled into the other 
wafer and a ~90 nm thick layer of amorphous silicon (aSi) was deposited. The 
two wafers were then aligned and anodically bonded (900 V, 3 h, 450 ˚C, 5 μbar) 
using a Karl Suss SB-6 wafer bonder (Munich, Germany). The bonded device 
was diced to expose the capillary channel at the University of Minnesota 
Electrical Engineering/Computer Science Machine Shop. NanoPorts™ 
(Upchurch Scientific, Oak Harbor, WA) were aligned over the access holes and 
attached using epoxy rings. Silver conductive epoxy was used to connect lead 
wires to the electrodes. The device was then heated on a hot plate to ~150 ˚C 
while under vacuum. A 20 μm i.d. × 150 μm o.d. fused silica capillary (Polymicro 
Technologies, Phoenix, AZ) was inserted into the capillary channel and bonded 
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into place by pulling Crystalbond™ 509 through the remaining space between 
the capillary and the channel. The µFFE device was then perfused with a 1M 
NaOH solution to remove aSi from the channels. 
2.3.3 Liquid Chromatography Conditions 
 A Thermo-Dionex UltiMate3000 RSLC nano pump with RS autosampler 
(Sunnyvale, CA) was used for LC separations. The analytical column (Thermo-
Dionex part number 164562) was 75 μm i.d. × 15 cm long packed with 2 μm 
Acclaim® PepMap C18 particles. For interface broadening experiments mobile 
phase A was H2O with 0.1% TFA and mobile phase B was 90:10 ACN:H2O with 
0.1% TFA. A gradient was applied from 10-80% B in 15 minutes, using 0.1 μL 
injection, and 300 nL/min flow rate. For 1D and 2D separations of Chromeo™ 
P503 labeled BSA tryptic digest, mobile phase A was H2O with 0.05% TFA and 
mobile phase B was 90:10 ACN:H2O with 0.05% TFA. A gradient from 30-95% B 
was applied in 10 minutes after holding at 10% B for 3 minutes. The injection 
volume was 1.0 μL and the flow rate was 300 nL/min. 
2.3.4 µFFE Conditions 
 The µFFE separation channel was coated with PEO following a previously 
described method to suppress electroosmotic flow (EOF) and minimize analyte 
adsorption.108  For 2D separations a syringe pump (Harvard Apparatus, Holliston, 
MA) was used to pump separation buffer through the µFFE device at a total flow 
rate of 0.5 mL/min (~0.15 cm/sec in the separation channel). Even though PEO 
has been shown to prevent the adsorption of proteins113, adsorption was 
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observed for the more hydrophobic peptides. As a result, 8 M urea was added to 
the µFFE separation buffer to denature larger peptides and reduce surface 
adsorption. Triton-X 100 was added to the buffer to improve stream stability.83 
During analysis a 150 V separation potential was applied to the left electrode 
while the right electrode was held at ground.  
2.3.5 Data Collection and Processing 
 An AZ100 stereomicroscope (Nikon Corp., Tokyo, Japan) mounted with a 
Cascade 512B CCD camera (Photometrics, Tucson, AZ) was used for 
fluorescence imaging. For the separation of rhodamine dyes the microscope was 
equipped with a GFP bandpass emission filter cube (Nikon Corp) containing two 
bandpass filters (450-490 and 500-550 nm) and a dichroic mirror (495 nm cutoff).  
For the Chromeo™ dye labeled digest a custom filter cube was used (Nikon 
Corp) containing two bandpass filters (470-500 nm and 570-640 nm) and a 
dichroic mirror (500 nm cutoff). Laser induced fluorescence (LIF) detection was 
performed using the 488 nm emission line of a 150 mW, argon-ion laser (Melles 
Griot, Carlsbad CA) expanded into a ~2.5 cm × ~150 μm line. The entire 
instrument setup was enclosed in a black, rubberized fabric (Thorlabs, Newton, 
NJ). For on-capillary detection a window was burned 70 cm down a 100 cm long 
piece of 20 μm i.d. × 280 μm o.d. fused silica capillary (Thermo-Dionex) which 
was attached to the end of the analytical column using a PTFE sleeve. The laser 
line was focused across the window and imaged using MetaVue software 
(Downington, PA). For 2D separations a separate piece of 20 μm i.d. × 280 μm 
capillary was connected to the capillary positioned in the µFFE separation 
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channel using a ZDV union (Upchurch Scientific). The total length from the 
column exit to the end of the capillary in the µFFE separation channel was        
70 cm. Acquisition rates for on-capillary and on-chip detection were 4 Hz and 2 
Hz, respectively, both with 4× gain. The nLC pump was controlled using 
Chromeleon v6.8 (Thermo-Dionex). Once logged, all data was then processed 
using in-house Matlab programs. Cutter v5.0114 and an open source program 
(Peak Finder, available at http://omics.pnl.gov/software) were used to process 
line scans and chromatograms, as well as determine peak capacities. For 2D 
separations the background was corrected using an orthogonal background 
correction as described by Filgueira et al, with a correction window of 50.115 
2.4 Results and Discussion  
 
Figure 2.2a shows a schematic demonstrating the principle of 2D          
nLC × µFFE separations.  The exit of the nLC is coupled directly into the µFFE 
separation.  Since µFFE performs a continuous separation, no complicated 
Figure 2.2: A) Schematic of the nLC × µFFE system. B) Image of a completed 
µFFE device. (1) buffer inlets (2) sample inlet capillary (3) electrodes (4) buffer 
outlets. C) Image of the nLC × µFFE interface. 
45 
 
injection or modulation mechanism is required to couple the two separations.  
Analyte peaks stream directly into the µFFE device as they elute off the nLC 
column where they are separated by a second mechanism.  Analytes are 
detected as they cross the LIF detection zone in the separation channel.   
The time it takes to reach the detection zone is determined by the first 
dimension nLC separation while the position where an analyte crosses the 
detection zone is determined by the second dimension µFFE separation.  The 
sampling time of the µFFE separation is determined by the cycle time of the CCD 
camera recording fluorescence across the detection zone.  In the current 
experiments cycle times ranged from 250 – 500 msec but significantly faster 
cycle times could easily be employed. 
2.4.1 Comparison of Interface Broadening 
In order to retain the peak capacity generated in the first dimension, 
remixing of the analytes must be minimized at the nLC × μFFE interface.  If 
significant dead volume is present in the interface broadening will occur and peak 
capacity will be lost.  Previously reported μFFE designs used a NanoPort™ to 
introduce the sample into the separation channel through an access hole drilled 
into the face of the device.75, 83, 104  However, the access holes were much larger 
than the inner diameter of the capillaries used, introducing an unacceptably large 
dead volume. (Figure 1.11)  An alternative design to minimize dead volume at 
the interface was explored.  Sample was introduced through a capillary inserted 
through the side into a channel etched in the device (Figures 2.2b. & 2.2c.).  This 
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arrangement allowed the capillary to extend into the separation channel.  
Capillary with an inner diameter of 20 µm was used to match the depth of the 
separation channel.  
 
Figure 2.3: nLC separation of 30 nM rhodamine 110 and 40 nM rhodamine 123 
comparing peak shape measured prior to (dashed line) and immediately after 
(solid line) the nLC × µFFE interface. Chromatograms were aligned to emphasize 
comparison in peak shape.  
  
A nLC separation of rhodamine 110 and rhodamine 123 was used to 
determine the extent of broadening that would occur at this side-on interface.  
Figure 2.3 compares the peak shapes for rhodamine 110 and rhodamine 123 
when detection is performed on-capillary to those recorded immediately after the 
interface inside of the μFFE separation channel. The peak shapes observed are 
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essentially identical, indicating that broadening introduced at the interface is 
minimal.  The width at half height of the rhodamine 110 peak was 2.8 seconds on 
capillary and 2.9 seconds immediately after the interface. Similarly, the width at 
half height of the rhodamine 123 peak was 3.0 seconds on capillary and 3.2 
seconds after the interface.  Overall, the side-on interface provides a simple 
means to interface a nLC column with a μFFE device with neglible contribution to 
band broadening. 
2.4.2 1D Liquid Chromatography of Peptides 
 A tryptic digest of BSA was chosen as a complex mixture of peptides 
suitable for challenging the peak capacity of the nLC and nLC × µFFE 
separations.  Peptides in the digest were fluorescently labelled using the 
fluorogenic Chromeo™ P503 reagent.116  Chromeo™ P503 reacts with amines 
resulting in the incorporation of a cationic fluorophore.  This is an important 
characteristic since replacing positively charged amines with cationic 





Figure 2.4: 1D nLC chromatogram of the Chromeo™ P503 labeled BSA tryptic 
digest. 
 
Figure 2.4 shows a nLC separation of the fluorescently labelled BSA 
digest.  Clearly, the complexity of this peptide mixture overwhelms the peak 
capacity of the 1D separation with numerous unresolved peaks observed across 
the 10 minute separation window.  Over 30 distinguishable peaks were observed, 
however only 5 were baseline resolved.  17 peaks were selected and the 
integration method in Peak Finder was used to estimate a 1D nLC peak capacity 
of 101. The last three well resolved peaks had an observed average efficiency of 
96,000 theoretical plates. 
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2.4.3 2D nLC × µFFE Performance 
 
 
Figures 2.5 and 2.6 demonstrate different views of a 2D nLC × µFFE 
separation of the same fluorescently labelled BSA digest analyzed using 1D nLC 
in Figure 2.4.  It is important to note that the nLC gradient and separation time 
did not need to be adjusted to accommodate the 2D separation and are identical 
to those used to generate the 1D chromatogram shown in Figure 2.4.  Clearly, 
the 2D separation is able to generate significantly higher peak capacity than the 
1D nLC separation.  With minimal optimization >65 resolved peaks could be 
distinguished in the 10 minute separation window, agreeing well with the 




predicted 74 tryptic peptides of BSA.  Figure 2.6b shows an expanded view of a 
high peak density region of the chromatogram.  Over 40 peaks are observed with 
what appears to be a random distribution across this 4 minute window.  Figures 
2.6c and 2.6d show 1D nLC chromatograms and µFFE line scans extracted from 
the full 2D separation, respectively.  These extracted chromatograms clearly 
demonstrate that the resolving power of each dimension was retained when nLC 
and µFFE were combined into a 2D separation.  
 
Figure 2.6: 2D nLC × µFFE separation of the Chromeo™ P503 labeled BSA 
tryptic digest. A) Top view B) Expanded view of the region enclosed in the dotted 
box in A) (i.e. 13.2 to 17.2 minutes in the first dimension and 3 to 7 mm in the 
second dimension) C) Extracted chromatogram from the first dimension 
measured at 4 mm on the µFFE device (shown as the vertical dashed line in A) 
D) Line scan across the second dimension taken at 14.0 minutes in the first 
dimension (shown as the horizontal dotted line in A) 
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 To determine the observed peak capacity of the 2D separation 29 peaks 
were chosen for further analysis using the integration method in Peak Finder.  
The observed peak capacity in the nLC dimension (1nc) was determined to be 98, 
essentially identical to the results obtained for the 1D nLC separation shown in 
Figure 2.4.  This peak capacity agrees well with the high efficiency peaks 
observed in the extracted chromatogram shown in Figure 2.6c.  Considering the 
500 msec sampling rate of the CCD camera, >12 measurements were taken 
across the 6.1 sec. average baseline width of a nLC peak.  Based on these 
values, eq. 1.5 predicts that 99% of the nLC peak capacity is retained through 
the interface, eliminating under sampling as a factor limiting the observed 2D 
peak capacity.  It should be noted that the CCD camera could easily be operated 
at much faster sampling rates to accommodate narrower peaks or faster 
separations in the first dimension. 
Figure 2.6d shows a µFFE linescan extracted from the full 2D separation.  
The average baseline width for peaks in the µFFE dimension was estimated to 
be 0.41 mm using the same 29 peaks used to determine the nLC dimension 
peak capacity.  Considering the 10 mm width of the separation channel the µFFE 
separation is able to generate a peak capacity of 24 (2nc).  Combining the nLC 
(1nc) and µFFE (
2nc) peak capacities according to eq. 1.1 gives rise to a 2D    
nLC × µFFE peak capacity (nc,2D) of 2,352 in a 10 minute separation window.  
For comparison, Mellors et al. recently reported a peak capacity of 1,400 in a 40 
minute separation window using UPLC coupled with microchip CE using a gated 
interface.97  The 2D nLC × µFFE separations reported here yield a peak capacity 
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production rate of 105 peaks/min, nearly double the previously reported rate 
using on-line LC×LC.14, 33 
 As described in eq. 1.6, the fractional coverage of separation space 
should also be taken into account to determine a more representative measure of 
the useable peak capacity.  Peaks are well distributed across the high density 
peak region shown in Figure 2.6b, suggesting that excellent orthogonality is 
achieved between the nLC and µFFE separations in this region.  Examining the 
full 2D separation window demonstrates that there are significant areas that are 
void of peaks, suggesting that peak capacity in these regions is inaccessible for 
the current combination of separation modes and sample.  For example, as 
shown Figure 2.6a, no analytes were deflected by more than 1 mm towards the 
cathode, while analytes were observed that were deflected almost 5 mm towards 
the anode. Using a minimum convex hull53, the fraction of separation space 
where peaks were observed (ƒ) was determined to be 33%, resulting in a 
realized 2D peak capacity of 776. Optimization of µFFE conditions to make better 
use of the full separation channel would dramatically improve ƒ and consequently 
the realized 2D peak capacity. Similarly, further exploration of combinations of 
nLC and µFFE to maximize orthogonality is expected to improve ƒ and realized 
2D peak capacity and will be discussed in greater detail in Chapter 5.  The use of 
Chromeo™ P503 is important for both of these approaches since it allows the 
native charge and isoelectric point of the peptides to be maintained through the 





 The continuous nature of µFFE separations facilitates a unique solution to 
the under sampling limitation of existing liquid phase 2D separations.  Coupling 
nLC with µFFE provided a 24-fold improvement in peak capacity with no increase 
in analysis time or restrictions on the nLC separation conditions.  Peak capacities 
as high as 2,352 were observed in a 10 minute separation window.  The CCD 
used for fluorescence measurements in the µFFE separation recorded an image 
of the detection zone every 500 msec.  Much faster CCD sampling rates are 
possible though suggesting that faster 2D separations are also feasible using this 
approach.  The described interface is simple with no complicated valving or 
timing required.  The µFFE device was coupled with commercially available nLC 
instrumentation suggesting widespread compatibility of the approach.  It should 
also be recognized that many combinations of nLC stationary phases and µFFE 
separation modes are available, suggesting that 2D nLC × µFFE could be 
successfully applied to a wide range of analyte mixtures. With the high 
performance of nLC × µFFE demonstrated, the following chapters will look in-
depth into two factors that can affect the peak capacity achievable with this 
system: 1) surface adsorption of analytes and its effect on broadening in each 












Effect of Surface Adsorption on Temporal and Spatial 
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 The adsorption of analytes onto surfaces presents a challenge for many 
separations, often becoming a significant source of peak broadening and 
asymmetry. This broadening can have a significant impact on the performance of 
a variety of applications of separations including the determination of dissociation 
constants and peak capacity of multidimensional separations. We have shown, 
however, that surface adsorption has no effect on peak position or spatial 
broadening in micro free flow (µFFE) separations. Surface adsorption still does 
affect the time it takes an analyte to travel through the µFFE separation channel 
and therefore contributes to temporal broadening. These results were confirmed 
using µFFE separations of fluorescein, rhodamine 110, and rhodamine 123 in a 
low ionic strength buffer to promote adsorption onto the surface of an all glass 
microfluidic device. Peak widths and asymmetries were measured in both 
temporal and spatial dimensions to assess the effect of adsorption. Under these 
conditions, rhodamine 123 exhibited significant interactions with the separation 
channel surface, causing increased peak broadening and asymmetry in the 
temporal dimension. Broadening or asymmetry in the spatial dimension was not 
significantly different than that of fluorescein, which was predicted to not interact 
with the capillary surface. The effect of strong surface interactions was 
demonstrated using µFFE separations of Chromeo™ P503 labeled myoglobin 
and cytochrome c. The proteins were well resolved and gave rise to symmetrical 
peaks in the dimension even though permanent adsorption onto the separation 




 Capillary electrophoresis (CE) has become a powerful tool in protein and 
peptide separations due to its high resolution, speed, and sensitivity.118 One 
limiting factor to the performance of CE, however, is the potential for protein-wall 
interactions which arise due to the ionization of the silica capillary surface above 
pH 3.119 These interactions introduce a resistance to mass transfer between the 
capillary wall and the bulk flow which results in band broadening and peak 
asymmetry.120, 121 The degree to which broadening and asymmetry occur is 
dependent on the type of interactions present between the molecule and the 
surface, as well as the rate of diffusion from the wall back into the bulk flow.122 A 
number of studies have been performed characterizing the effect of surface 
adsorption on peak broadening, elution time delays, and electroosmotic    
flow.123-125  Numerous methods have been implemented to mediate the effect of 
wall adsorption, with the most common being the use of buffer modifications, 
using polymers to coat the capillary surface, or combinations of both.126-131 
Without addressing wall adsorption as a major source of band broadening, CE 
becomes impractical for the analysis of larger biomolecules seen in the omics 
fields, especially when used for the study of protein-ligand affinity.120, 123, 132 
Surface interactions with ionized silica also impacts other time based 
separations, such as liquid chromatography (LC). The silica surface of stationary 
phase supports commonly used in LC are often inhomogeneous, containing 
unevenly distributed silanol groups which can have interactions with both the 
mobile phase and solute.133-135 These interactions result in poor peak shape and 
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lowered separation performance, often requiring the addition of ion pairing 
agents to overcome these effects.136 
Micro free flow electrophoresis (µFFE) is a separation technique where 
analytes are introduced as a continuous stream into a planar separation channel. 
Unlike traditional CE where the electric field is applied parallel to the direction of 
flow, the field in µFFE is applied perpendicularly causing analytes to deflect 
laterally based on their mobilities (Figure 1.8). As mentioned in previous chapters 
devices have been fabricated in a variety materials such as 
polydimethylsiloxane68-71 (PDMS), poly(methyl methacrylate) (PMMA)72, biaxially-
oriented polyethylene terephthalate (Mylar™)73, and glass74-80 for the separations 
of fluorescent dyes71, 75, amino acids66, 69, 71, proteins67, 72, 76, 98, 100, 101, 
organelles70, 77, 102, and whole cells.70 Continuous analysis has allowed µFFE to 
be used in a number of unique applications including: measuring the 
electrophoretic mobility of mitochondria102, quantifying the dissociation constants 
of aptamer-protein complexes104,  isolating aptamers by SELEX105, and rapid 
optimization of buffer conditions for CE separations.103 Chapter 2 described the 
coupling of µFFE with nano LC (nLC) to perform high peak capacity 
multidimensional separations of peptides.85 Understanding how surface 
adsorption affects μFFE separations is important for further development of these 
applications. 
Raymond et al. were the first to demonstrate µFFE in 1994.66 By analogy 
to mechanisms observed in CE and preparative FFE, they proposed potential 









2    (3.1) 
where the observed total variance of an analyte band (𝜎𝑡𝑜𝑡𝑎𝑙
2 ) is determined by 
the sum of the variances from individual broadening sources including initial 
stream width (𝜎𝑖𝑛𝑗
2 ), diffusion (𝜎𝐷
2), hydrodynamic broadening (𝜎𝐻𝐷
2 ), adsorption 
(𝜎𝐴𝐷𝑆
2 ), and Joule heating (𝜎𝐽𝐻
2 ).67  As highlighted in Chapter 1, Fonslow and 
Bowser experimentally verified the parameters that contribute to injection (𝜎𝑖𝑛𝑗
2 ), 
diffusion (𝜎𝐷
2) and hydrodynamic broadening (𝜎𝐻𝐷
2 ) in µFFE108: 
𝜎𝑡𝑜𝑡𝑎𝑙













 (3.2)  
  
where (𝑤𝑖𝑛𝑗) is the width of the sample stream at the inlet, 𝐷 is the analyte 
diffusion coefficient, 𝐿 is the vertical distance between the sample inlet and the 
detection zone, 𝑣 is the linear velocity of the buffer, ℎ is the height of the 
separation channel and 𝑑 is the lateral deflection distance of the analyte.  It was 
determined that diffusion governed broadening at low flow rates, while 
hydrodynamic broadening dominated for analytes with significant deflection 
distances, especially at high combinations of buffer velocity and electric field. It 
should be noted that in this study conditions were chosen to minimize the 
potential effects of surface adsorption and Joule heating. This chapter will 
provide a detailed description of the effect surface adsorption has on band 





3.3.1 Chemicals and Reagents 
 All solutions were made using deionized water (18.3 MΩ, Milli-Q; Millipore, 
Bedford, MA) and filtered through a 0.22 μm nitrocellulose membrane filter 
(Fisher Scientific, Fairlawn, NJ) unless otherwise stated. The µFFE and CE 
separation buffer for all experiments contained 300 μM Triton X-100 and 25 mM 
HEPES (Sigma-Aldrich, St. Louis, MO), adjusted to pH=7.00 using 1 M NaOH 
(Macron Chemicals, Center Valley, PA). Eluents for nLC were prepared using 
LC-MS grade water, acetonitrile, and methanol (J.T. Baker, Phillipsburg, NJ). 
Trifluoroacetic acid (TFA) was purchased from Sigma-Aldrich. Stock solutions of 
rhodamine 123, rhodamine 110, and fluorescein (Sigma-Aldrich) were prepared 
in 190 proof ethanol (Fisher Scientific) at concentrations of 1.2 mg/mL, 1.2 
mg/mL, and 1.5 mg/mL, respectively. Stock solutions of myoglobin (equine 
skeletal muscle, Sigma-Aldrich) and cytochrome c (bovine heart, Sigma-Aldrich) 
were prepared in 10 mM NaHCO3 (Mallinkrodt, Paris, KY) in water at 
concentrations of 1.1 mg/mL and 1.2 mg/mL, respectively. A 10 mg/mL 
Chromeo™ P503 (Active Motif, Carlsbad, CA) solution in DMSO (Sigma-Aldrich) 
was prepared to label the proteins. To perform the labeling, 10 μL of the 
Chromeo™ P503 dye solution was added to 490 μL of each protein solution and 
vortexed for 10 minutes. The vials were allowed to incubate at room temperature 
for 24 hours before any separations were performed. The labeled proteins were 
stored at 0 ˚C when not in use. Piranha solution (4:1 H2SO4:H2O2) (Ashland 
Chemical, Dublin, OH) was used to clean glass wafers and etch Ti. GE-6 (Acton 
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Technologies, Inc., Pittston, PA) was used to etch Au. Concentrated HF (49%) 
(Ashland Chemical) was used to etch glass wafers. Silver conductive epoxy (MG 
Chemicals, Surrey, BC, Canada) was used to make electrical connections to the 
μFFE device. Fused silica capillaries (Polymicro Technologies, Phoenix, AZ) 
were fixed into the devices using Crystalbond™ 509 (SPI Supplies, West 
Chester, PA).  
3.3.2 Device Fabrication 
 Fabrication followed the procedure previously described by Geiger et. al.85 
in Chapter 1. Briefly, an 85 μm channel was etched into two 1.1 mm borofloat® 
glass wafers (Precision Glass & Optics, Santa Ana, CA) using standard 
photolithography to allow for the capillary connection. A second photolithography 
step was performed to pattern and etch 30 μm deep electrode channels. Finally, 
a third photolithography step etched the separation channel to 10 μm. These 
etching steps resulted in two wafers having a 125 μm capillary channel (~250 μm 
wide), 40 μm electrode channels, and a 10 μm deep × 1 cm wide × 2.5 cm long 
separation channel.  (See Figure 2.1 in Section 2.3.2 for CAD files of the masks) 
A Temescal electron beam evaporator was used to deposit 150 nm thick layers 
of Ti and Au to one of the wafers. A photolithography step was performed to 
pattern the electrodes by removing unwanted Ti and Au. The other wafer had 1 
mm diameter holes drilled for inlets, outlets, and over the electrodes. A ~90 nm 
thick layer of amorphous silicon was deposited. The two wafers were aligned 
under a microscope and anodically bonded (900 V, 3h, 450 ˚C, 5 μbar) using a 
Karl Suss SB-6 wafer bonder (Munich, Germany). The bonded device was cut to 
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expose the capillary channel at the University of Minnesota Electrical 
Engineering/Computer Science Machine Shop. NanoPorts™ (Upchurch 
Scientific, Oak Harbor, WA) were aligned over the access holes and attached 
using epoxy rings (IDEX Lake Forest, Il). Silver conductive epoxy was used to 
connect lead wires to the electrodes. The device was then heated on a hot plate 
to ~120 ˚C while under vacuum. A 20 μm i.d. x 150 µm o.d. fused silica capillary 
was inserted into the capillary channel and Crystalbond™ 509 was pulled 
through the remaining space between the capillary and channel to bond it in 
place. The chip was then perfused with 1M NaOH solution to remove the residual 
amorphous silica from the channels. 
3.3.3 Capillary Electrophoresis Conditions 
 CE was performed using a P/ACE MDQ system (Beckman Coulter, 
Fullterton, CA equipped with a LIF detector (ex = 488 nm; em = 520 nm) and a 
10 mW, 488 nm diode pumped solid state laser (Sapphire, Coherent, Santa 
Clara, CA). The separation capillary was 40 cm in total length, 50 um i.d. and the 
detector was 33 cm from the inlet.  For protein separations, the capillary was 
rinsed at 20 psi with 0.1 M NaOH for 5 min, H2O for 2 min, and separation buffer 
for 2 min at 20 psi between each run.  Sample injections were performed at 0.1 
psi for 2 seconds. The voltage applied was 30 kV. For dye separations, the 
capillary was rinsed at 20 psi with 0.1 M NaOH for 1 min, H2O for 1 min, and 
separation buffer for 10 min between each run.  Sample injections were 
performed at 0.1 psi for 2 seconds. The voltage applied was 30 kV for 20 min. 
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3.3.4 Liquid Chromatography Conditions 
 A Thermo-Dionex UltiMate3000 RSLC nano pump with WPS autosampler 
(Sunnyvale, CA) was used for LC separations. The analytical column (Thermo-
Dionex Part number 164562) was 75 μm i.d. × 15 cm long packed with 2 μm 
Acclaim® PepMap C18 particles. For the fluorescent dye separations mobile 
phase A was 100% H2O and mobile phase B was 90:10 MeOH:H2O. An isocratic 
composition of 85:15 B:A was chosen, using 0.1 µL injection and a 300 nL/min 
flow rate. For protein adsorption experiments mobile phase A was H2O with 0.1% 
TFA and mobile phase B was 90:10 ACN:H2O with 0.1% TFA. An isocratic 
composition of 60:40 B:A was chosen, using 0.1 µL injection and a 300 nL/min 
flow rate. 
3.3.5 µFFE Conditions 
 For fluorescent dye separations a syringe pump (Harvard Apparatus, 
Holliston, MA) was used to pump separation buffer through the FFE device at a 
flow rate of 0.5 mL/min (~0.15 cm/sec in the separation channel). Upon injection, 
+50 V was applied to the right electrode while the left was held at ground. The 
same buffer flow rate was used for protein separations, and +150 V was applied 
across the device.  For continuous, direct injection separations +75 V was 
applied.  
3.3.6 Data Collection and Processing 
 An AZ100 stereomicroscope (Nikon Corp., Tokyo, Japan) mounted with a 
Cascade 512B CCD camera (Photometrics, Tucson, AZ) was used for µFFE LIF 
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detection and fluorescence imaging. For fluorescent dyes the microscope was 
equipped with a GFP bandpass emission filter cube (Nikon Corp) containing two 
bandpass filters (450-490 and 500-550 nm) and a dichroic mirror (495 nm cutoff).  
For the Chromeo™ dye labeled proteins a custom filter cube was used (Nikon 
Corp) containing two bandpass filters (470-500 nm and 570-640 nm) and a 
dichroic mirror (500 nm cutoff). Laser induced fluorescence (LIF) detection was 
performed using a 150 mW, diode pumped solid state laser (Coherent) expanded 
into a ~2.5 cm × ~150 μm line. For fluorescent dyes the line was positioned at 
various distances down the chip to measure broadening effects. For proteins the 
line was positioned 12.50 mm down the separation channel. The entire 
instrument was enclosed in a light-tight box (Newport, Irvine, CA). For on-
capillary detection a window was burned 70 cm down a 100 cm long piece of    
20 μm i.d. x 280 μm o.d. fused silica capillary (Thermo-Dionex) which was 
attached to the end of the nLC column using a PTFE sleeve. For all adsorption 
experiments a separate piece of 20 μm i.d. × 280 μm capillary was connected to 
the capillary placed in the chip using a ZDV union (Upchurch Scientific). The total 
length from the column to the end of the capillary in the µFFE device was 70 cm. 
Acquisition rates for on-capillary and on-chip detection were 4 Hz, with a 1× gain. 
The nLC pump was controlled using Chromeleon v6.8 software (Thermo-
Dionex). Once logged, all data was processed using in-house Matlab programs. 
Cutter v5.0114 was used to process line scans and chromatograms. Asymmetry 
values were calculated by fitting peaks to a 3rd degree Gaussian function using 
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the CurvFit application in Matlab. Peaks were assessed at 1/10 the max height to 
determine asymmetry. 
3.4 Results and Discussion 
 In CE analyte surface adsorption results in distorted peak shapes. These 
distortions can manifest as band broadening and changes in peak     
symmetry120, 121, 137 depending on the interactions between the analyte and the 
wall.122  
 Specifically, peak asymmetry can be incurred since the analyte will desorb 
over time, leading to peak tailing.  The asymmetry of a peak is defined as the 
ratio of the width of the peak tail to the width of the peak front, taken at 1/10 the 
of the peak height. Peaks with ratios greater than 2 are often regarded as 
asymmetric. (Figure 3.1) 
Figure 3.1: Calculation of peak asymmetry. Asymmetry (As) is the ratio of the 
peak tail (B) to peak front (A) taken at 10% of the peak height (h). Peak shapes 






Figure 3.2: A) Schematic illustrating three hypothetical flow paths through a 
µFFE separation channel. Analyte 1 does not interact with the separation 
channel surface. Analytes 2 and 3 interact with the surface with increasing affinity 
giving rise to temporal broadening. B) Illustration of the adsorption/desorption 
equilibrium of an anlyte interacting with the glass surface of the separation 
channel. Note that the analyte is immobilized while adsorbed onto the surface.  
  
 The effect of surface adsorption on peak shape in µFFE is less clear.  
Figure 3.2A illustrates three hypothetical flow paths through a µFFE separation 
chamber.  Analyte #1 does not interact with the surface as it travels through the 
device, giving rise to a well-defined peak with a width determined by the 
broadening terms listed in eq. 3.2.  Analytes 2 and 3 do interact with the surface 
of the flow chamber according to the equilibrium shown in Figure 3.2B.  While in 
solution they travel on a trajectory determined by their mobility and the linear 
velocity of the buffer.  When the analytes adsorb onto the surface they remain 
fixed in place with no motion in either the lateral (mobility) or vertical (pressure 
driven flow) directions.  When an analyte desorbs back into solution it resumes 
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its original trajectory as determined by the electric field and pressure driven flow.  
Since analytes do not move while adsorbed and the surface interactions do not 
affect their trajectory while in solution, the extent of an analyte’s interaction with 
the surface does not affect the position where it crosses the detection zone.  
Therefore, wall interactions cannot contribute to broadening in the spatial 
dimension as an analyte moves through the µFFE separation chamber.  In 
contrast, the time it takes an analyte to move through the separation chamber is 
clearly affected by the time that an analyte spends adsorbed onto the surface.  If 
a discrete bolus of analyte (i.e. peak) is introduced into the µFFE separation 
chamber (as shown in Figure 3.2A), increased surface interaction will contribute 
to broadening in the time dimension as it travels through the device.  Therefore to 
fully assess the effect of surface adsorption on µFFE separations both spatial 







3.4.1 Surface Adsorption of Fluorescent Dyes 
Figure 3.3A shows a CE electropherogram of three fluorescent dyes 
(fluorescein, rhodamine 110 and rhodamine 123) commonly used to assess 
separation performance.  The separation is performed in a HEPES/Triton X-100 
buffer commonly used in µFFE separations to minimize current in the separation 
channel.138  In this low ionic strength buffer even weak ionic interactions with the 
silica surface cause pronounced effects on peak shape.  Fluorescein bears a -2 
charge at pH 7 and is therefore not expected to interact with the silica surface.  
Figure 3.3: A) CE electropherogram and B) µFFE separation of (1) rhodamine 
123, (2) rhodamine 110 and (3) fluorescein using a 25 mM, 300 µM Triton X-100, 
pH = 7.00 separation buffer. 
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Conversely, rhodamine 123 bears a +1 charge and interactions with the negative 
surface are expected.  Rhodamine 110 is zwitterionic and predicted to exhibit a 
weak interaction.  The peak shapes in the electropherogram shown in Figure 
3.3A confirm the predicted trend.  Fluorescein and rhodamine 110 both give rise 
to well defined peaks, with asymmetry values of 1.2 and 2.3, respectively.  
Distortion of the rhodamine 123 peak is consistent with surface adsorption.  
Significant tailing over a period of several minutes is observed, giving rise to a 
peak asymmetry value of 17.1.  Wall interactions are severe enough to even 
reverse the expected migration order of rhodamine 110 and rhodamine 123. 
Figure 3.3B shows a µFFE linescan of the same three fluorescent dyes 
separated in the same low ionic strength HEPES/Triton X-100 buffer.  While the 
efficiency of the separation is clearly lower than that of CE, the peak shapes are 
strikingly symmetric.  Asymmetry values for the rhodamine 123, rhodamine 110, 
and fluorescein peaks were 0.9, 1.0, and 1.1, respectively.  The borofloat® glass 
surface of the µFFE flow chamber is not significantly different than that of the 
fused silica surface of the CE capillary.  Rhodamine 123 still adsorbs onto the 
surface, but as predicted this interaction has no effect on spatial broadening in 
the µFFE separation.  It should be noted that the order of the peaks in the µFFE 
separation follow the expected trend based on analyte charge, further reinforcing 
the premise that wall interactions do not affect the position where analytes cross 
the detection zone. 
While the data presented in Figure 3.3 supports the hypothesis that wall 
interactions do not affect spatial broadening in µFFE, it does not address the 
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effect on temporal broadening.  It would also be better to directly demonstrate 
that adsorption is indeed occurring in the µFFE device rather than rely on 
comparisons with CE data.  To assess temporal broadening we must introduce a 
discrete bolus of analyte into the µFFE device.  To accomplish this we used 
instrumentation previously developed to perform two-dimensional nLC × µFFE 
separations.85  Analytes were injected onto an nLC column and then immediately 
eluted off the column and into the µFFE device as a discrete bolus. 
 Figure 3.4 shows 2D nLC × µFFE separations of fluorescein, rhodamine 
110 and rhodamine 123 recorded at different positions along the length of the 
µFFE channel.  The first dimension is the time required to reach the detector (i.e. 
nLC retention time) while the second dimension is the position that the analyte 
crossed the detection zone (i.e. µFFE deflection distance).  Although the intent 
was to inject a discrete analyte bolus into the µFFE device, some nLC retention 
is observed as evidenced by differences in observed elution times.  Resolution in 
the µFFE dimension increased as analytes moved through the separation 
channel due to increased time in the electric field.  Chromatograms for 
fluorescein, rhodamine 110 and rhodamine 123 were extracted from the 2D 
separations shown in Figure 3.4 to more clearly illustrate the extent of temporal 
broadening as analytes travelled through the µFFE channel (see Figure 3.5).  
Individual chromatograms are generated since each analyte crosses the µFFE 
detection zone at a different spatial position. Near the entrance of the µFFE 
separation chamber, all three analytes gave rise to relatively well formed peaks 
as determined by their elution off the nLC column.   
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Figure 3.4: 2D nLC × µFFE separations of (1) rhodamine 123, (2) rhodamine 
110, and (3) fluorescein recorded in the µFFE separation channel (A) 7.00 mm, 
(B) 12.50 mm, and (C) 17.75 mm from the sample inlet. The first dimension is the 
nLC elution time and the second dimension is the µFFE deflection distance. 
Dashed lines indicate the time points used to generate the µFFE linescans 
shown in Figure 3.5B. 
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As analytes progressed through the flow chamber, distinct differences are 
observed.  The peaks for fluorescein and rhodamine 110 were relatively 
unchanged suggesting that temporal broadening introduced during the µFFE 
separation is minimal.  Conversely, the rhodamine 123 peak broadened 
dramatically, consistent with the temporal broadening expected from surface 
adsorption.  Surface adsorption was strong enough to induce a shift in elution 
time as rhodamine 123 flows through the µFFE flow chamber.  Figure 3.5C 
illustrates these trends more clearly.  No significant change in peak width in the 
temporal dimension was observed as fluorescein moves through the µFFE flow 
chamber.  The peak width of rhodamine 123 increases from 9.3 to 49.7 seconds, 
suggesting that significant surface adsorption occurs in the µFFE separation 
chamber, which in turn contributes to temporal broadening.   
Figure 3.5B shows µFFE linescans extracted from the 2D separations 
shown in Figure 3.4.  The time points used to generate the extracted linescans 
are indicated by the dashed lines in Figure 3.4 and the color coded lines in 
Figure 3.5A.  Again, detection was performed at different positions along the 
length of the flow channel to determine how peak shapes changed as analytes 
progressed through the µFFE separation. As expected, separation of fluorescein, 
rhodamine 110 and rhodamine 123 increased as the analytes travelled further 
through the separation channel.  Broadening also occurred according to the 
diffusion and hydrodynamic terms described in equation 3.2.  It is important to 
note that no significant difference in spatial broadening was observed between 
fluorescein and rhodamine 123.  This is shown clearly in Figure 3.5D where the 
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peak widths of fluorescein and rhodamine 123 both increase linearly as they 
progress through the separation channel as would be expected for spatial 
broadening determined by diffusion and hydrodynamic sources. 







Figure 3.5: A) Extracted chromatograms of (1) rhodamine 123, (2) rhodamine 110, 
and (3) fluorescein measured in the µFFE separation channel 7.00 mm, 12.50 mm, 
and 17.75 mm from the sample inlet. B) Extracted µFFE linescans taken at various 
separation times (indicated by vertical lines of the corresponding color in (A) as (1) 
rhodamine 123, (2) rhodamine 110, and (3) fluorescein move from 7.00 mm to 
17.75 mm from the inlet in the separation channel. Linescans were taken at 283.5 
sec (blue) and 306.75 sec (red) at 7.00 mm, 289.25 sec (blue), 303.5 sec (red), 
and 325.25 sec (green) at 12.50 mm, and 296.0 sec (blue), 309.75 sec (red) , and 
342.75 sec (green) at 17.75 mm. C) Temporal peak widths at helf height for 
fluorescein (blue circles) and rhodmaine 123 (red squares) at increasing distance 
from the sample inlet in the separation channel. D) spatial peak widths at half 
height for fluorescein (blue circles) and rhodamine 123 (red squares) at increasing 
distance from the sample inlet in the separation channel. Error bars are the 
standard error of the mean (n=3). Rhodamine 100 co-migrates with the nLC 
solvent through the µFFE separation channel, introducing an artifact that affected 
its peak shape. Rhodamine 110 was omitted from C) and D) for this reason. 
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The combined trends confirm our hypothesis that while analyte surface 
interactions contribute to broadening in the temporal dimension, no effect is 




Figure 3.6 shows the asymmetry, in both the temporal (A-C) and spatial 
(D) dimensions, of the fluorescein, rhodamine 110 and rhodamine 123 peaks as 
they move through the µFFE separation channel.  The asymmetry of the 
fluorescein and rhodamine 110 peaks did not change significantly as they moved 
Figure 3.6: Plots of peak asymmetry in the temporal (A-C) and spatial (D) 
dimensions vs. distance traveled through the separation channel for fluorescein (blue 
circles), rhodamine 123 (red squares) and rhodamine 110 (green diamonds). Error 
bars are the standard error of the mean (n=3). 
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through the separation chamber.  The initial asymmetry generated during their 
fast elution off the nLC column was maintained through the µFFE separation.  
Asymmetry in the temporal dimension increased for rhodamine 123 as expected 
due to its interaction with the separation channel surface.  In contrast, µFFE peak 
shapes in the spatial dimension were nearly perfectly symmetrical in all cases, 
reinforcing the premise that surface interactions do not affect peak shape in the 
spatial dimension.  It should also be noted that the temporal asymmetry of the 
peaks entering the flow chamber did not translate into spatial asymmetry in the 
µFFE separation. 
3.4.2 Impact on Protein Separations 
The surface interactions exhibited by rhodamine 123 in the HEPES/Triton 
X-100 buffer system were relatively modest.  Much stronger interactions and 
consequently more severe peak distortions are commonly observed during CE 
analyses of proteins.  We used Chromeo™ P503 labeled myoglobin and 
cytochrome c as model analytes to determine the effect of strong surface 
interactions on temporal and spatial broadening in µFFE.  Figure 8A shows CE 
electropherograms of Chromeo™ P503 labeled myoglobin and cytochrome c 
using our low ionic strength buffer in a bare fused silica capillary.  As expected 
for these non-ideal conditions, significant surface adsorption occurs, giving rise to 
extensive peak tailing.  The baseline never returns to zero after the initial protein 
peaks migrate through the capillary suggesting that permanent adsorption onto 




 Figure 3.7B shows individual 1D nLC chromatograms for Chromeo™ 
P503 labeled myoglobin and cytochrome c.  TFA added to the mobile phase 
suppressed ionization of exposed silanol groups, minimizing surface interactions 
to generate good peak shapes.  Initial peak widths were 97.5 and 95.0 seconds 
for myoglobin and cytochrome c, respectively. These well-defined peaks allowed 
us to inject discrete boluses of myoglobin and cytochrome c onto the µFFE 
device to assess spatial and temporal broadening.  Figure 3.8 shows a 2D       
nLC × µFFE separation of myoglobin and cytochrome C.  Extensive temporal 
Figure 3.7: A) CE electropherogram of Chromeo™ P503 labeled cytochrome c 
and myoglobin. (B) nLC chromatograms measured on-column. (C) Extracted 
chromatograms recorded in the µFFE separation channel 12.5 mm from the 
sample inlet. (D) Extracted µFFE linescan recorded at 4.2 minutes. 
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broadening is observed with peaks extending for >15 minutes after they initially 
reach the detector.  Figure 3.7C shows extracted chromatograms for each 
protein after they travelled 12.5 mm through the μFFE separation chamber.  
Significant temporal broadening is observed due to protein adsorption onto the 
µFFE surface.  The Chromeo™ P503 label preserves the native charge on the 
protein117. At a buffer pH of 7.00 myglobin (pI ~7) would be near neutral and 
cytochrome c (pI ~9.6) would be positively charged.  Interactions at the wall can 
be attributed not only to net charge, but also local regions of positive charge or 
hydrophobic pockets.139 Peak tailing was observed for >15 minutes after initial 
observation of the protein peaks.  Proteins remained permanently adsorbed onto 
the glass surface requiring a NaOH rinse to regenerate the surface.   
 
Figure 3.8: 2D nLC × µFFE separation of Chromeo™ P503 labeled (1) 
cytochrome c and (2) myoglobin. Detection was performed in the µFFE separation 
channel 12.50 mm from the sample inlet. 
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Figure 3.7D shows a µFFE linescan recorded at 4.2 minutes during the same 
Chromeo™ P503 labeled myoglobin and cytochrome c separation.  Despite the 
dramatic surface adsorption that is evident in Figure 8C, spatial broadening in the 
µFFE separation remains unaffected.  Only modest peak asymmetry is observed 
in the µFFE dimension, which can be attributed to heterogeneity in protein 
structure or labelling efficiency.  The myoglobin and cytochrome c peaks are well 
resolved and symmetrical reinforcing that even severe surface adsorption does 
not contribute to spatial broadening in µFFE separations. 
It should be noted that myoglobin and cytochrome c were chosen to 
present an extreme case of surface adsorption.  The reversible adsorption shown 
in Figure 3.2B will be much more common.  Irreversible adsorption to the 
separation channel will impact quantification.  Signal intensity will decrease if 
analyte is adsorbed before reaching the detection zone.  Conversely, irreversible 
adsorption of analytes in the detection zone may permit very long exposure 
times, potentially improving S/N.140 
3.5 Conclusions 
 We have clearly demonstrated that surface adsorption does not contribute 
to spatial broadening in µFFE separations.  µFFE may therefore be particularly 
well suited for performing separations of analytes that exhibit strong surface 
interactions.  For example, the separations of many biomolecules, such as 
proteins and lipids, are challenging due to their propensity for interacting with a 
variety of surfaces.  In contrast, surface adsorption does contribute to temporal 
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broadening in µFFE.  It is therefore important to consider the effect of surface 
adsorption on the temporal response of a µFFE analysis when used to monitor 
changes in analyte concentration or composition over time.141, 142  Surface 
interactions can be mediated using many of the same surface modifications 
previously developed for CE separations.126-131  Eliminating surface interactions 
will be especially important for two-dimensional separations where temporal 
broadening in the µFFE separation will result in a loss of peak capacity 
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 As shown in Chapters 1 and 2, multidimensional separations present a 
unique opportunity for generating the high peak capacities necessary for the 
analysis of complex biological mixtures. In Chapter 2, the coupling of nano-liquid 
chromatography with micro free flow electrophoresis (2D nLC × µFFE) was 
shown to produce high peak capacity separations of fluorescently labelled 
peptide mixtures. Currently, µFFE largely relies on laser induced fluorescence 
(LIF) detection. We have demonstrated that the choice of fluorescent label 
significantly affects the orthogonality and peak capacity of 2D nLC × µFFE 
separations of peptides and amino acids.  
 Of the labeling reagents assessed. Chromeo™ P503 performed the best 
for 2D nLC × µFFE separations of peptides. A Chromeo™ P503 labeled BSA 
tryptic digest produced a 2D separation that made effective use of the available 
separation space (48%), generating a corrected peak capacity of 521 in a 5 
minute separation window. 2D nLC × µFFE separations of NBD-F labeled 
peptides produced similar orthogonality and peak capacity but this reagent was 
able to react with multiple reaction sites, producing an unnecessarily complex 
analyte mixture. NBD-F performed the best for 2D nLC × µFFE separations of 
amino acids. NBD-F labeled amino acids produced 2D separations that covered 
36% of the available separation space, generating a corrected peak capacity of 
95 in a 75 second separation window. Chromeo™ P503 and Alexa Fluor® 488 
labeled amino acids were not effectively separated in the µFFE dimension, giving 




 Traditional chromatographic and electrophoretic separations have been 
powerful analytical tools in the analysis of mixtures.118 However, the complexity 
of environmental and biomedical samples often exceeds the peak capacity of 
traditional one-dimensional (1D) separations (Chapter 1). Over the last several 
decades, multi-dimensional separations pairing two or more 1D separation 
techniques have been introduced as high peak capacity alternatives for complex 
samples. Online comprehensive separations using LC, GC, and CE in various 
combinations have all been demonstrated.14, 16-20, 23-25, 143, 144 These 2D 
separations generate dramatically increased peak capacity when compared to 
1D separations.35  Total ideal peak capacities of over 1500 have been reported 
for on-line LCxLC in 15 minutes.14  Giddings defined the ideal maximum peak 
capacity that a 2D separation could attain (nc,2D) as the product of the peak 
capacities from the first (1nc) and second (
2nc) dimension separations. 
35 
 To achieve the ideal 2D peak capacity described in eq. 1 there must be no 
remixing or under sampling at the interface between the two separations and the 
separation mechanisms must be orthogonal.35, 40  These correction factors are 
represented by the fraction of the separation space occupied by peaks, ƒ, and 
the under sampling of the first dimension, related to the ratio of the second 
dimension sampling time (ts) and first dimension peak width (






× 𝑓 (4.1) 
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In equation 4.1, 
1
𝛽
 defines the fraction of peak capacity lost due to under 
sampling. To avoid losses in peak capacity due to under sampling, the second 
dimension separation must operate much faster than the width of the peaks 
eluting off the first dimension separation.  This has proven challenging especially 
in liquid phase separations, where 2D separation times of hours are not 
uncommon.145 Under sampling of the first dimension in LC×LC can easily lead to 
50% or greater loss in peak capacity before the second separation even occurs 
(Chapter 1).40, 41  
In Chapter 2, it was demonstrated that under sampling could essentially 
be eliminated by using micro free-flow electrophoresis (µFFE) as the second 
dimension in a 2D separation.85  Coupling nLC with µFFE generated peptide 
separations with a useable peak capacity of 776 in a 10 minute separation 
window.  µFFE is a continuous separation technique where samples are 
introduced to the top of a planar separation channel and driven by pressure 
flow.146 Unlike traditional capillary electrophoresis, where the electric field is 
applied along the flow direction, the field in µFFE is applied perpendicularly. 
Analyte’s flow paths are deflected in the electric field and separate based on their 
electrophoretic mobilities. Since first demonstrated by Raymond et. al.66 µFFE 
devices have been fabricated in a wide array of materials including silicon66, 67, 
polydimethylsiloxane (PDMS)68-71, and glass74-80. µFFE has been used to 
separate fluorescent dyes71, 75, amino acids66, 68, 69, peptides85,               
proteins67, 72, 76, 98, 100, 101, organelles70, 77, 102, and whole cells70.  Unique µFFE 
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applications include measurement of protein binding142, aptamer selection147 and 
optimization of electrophoretic separation conditions.141  
Due to its high sensitivity and simplicity, laser induced fluorescence (LIF) 
has been the most commonly used detection method for µFFE to date.148  While 
the sensitivity provided by LIF simplifies detection in microscale environments, 
this technique presents additional analytical challenges.  In order to use LIF 
detection the sample must either be natively fluorescent or labeled with a 
fluorescent tag.  Fluorescent labels have been developed for the analysis of a 
range of analytes including proteins, peptides, amino acids and                  
nucleic acids.149-151  These labels make high sensitivity LIF detection possible, 
but necessarily modify the sample.  Labeling heterogeneity is possible for 
analytes with more than one reactive site.116, 152 The chemical properties of the 
analytes are also changed.  For example, labelling amine sites on a protein can 
dramatically affect a protein’s isoelectric point.117, 153  
Adding the same functional group to every molecule in a sample makes 
the analytes more similar to each other and, therefore, more difficult to separate.  
The chemical diversity of the analytes in a mixture can greatly impact 
orthogonality of a separation.44  Orthogonality refers to how efficiently the 
separation space is used in a 2D separation. Giddings proposed several factors 
that determine orthogonality. The most commonly addressed is the separation 
dimensionality, which is the number of separation mechanisms employed in the 
system. For example, the number of columns linked together in multidimensional 
GC or LC separation. The second factor is the sample dimensionality, which is 
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the number of independent variables needed to identify the components of the 
sample. It follows that if the sample does not have enough complexity, a 
multidimensional separation would offer minimal to no gains in peak capacity.44  
The separation and sample dimensionality both contribute to the observed 
orthogonality of a separation.  There are many methods for determining the 
orthogonality of a multidimensional separation including correlation    
coefficients45, 46, fractal dimensionality47, geometric approaches such as a fan 
area48, peak counting49, and modified forms of box counting50-52. Rutan et. al. 
have demonstrated the merits of the minimum convex hull method for estimating 
the fraction coverage (ƒ).53 The minimum convex hull defines the usable 
separation space by drawing the smallest convex polygon (i.e. all interior angles 
are ≤180º) around the outermost peaks of the 2D separation. It represents the 
area in which peaks could theoretically occupy in a separation, which agrees well 
with Giddings’ original definition.44 
 It appears clear that labelling an analyte mixture with a fluorophore will 
impact its sample dimensionality and therefore, the orthogonality that will be 
observed in a 2D separation.  Since 2D µFFE separations are, at this point, 
largely dependent on LIF detection, it is important to determine what extent 
different labels will limit the orthogonality of common separations.  In the current 
chapter, the effect of three commonly used labeling reagents (Chromeo™ P503, 
NBD-F and Alexa Fluor® 488) on the observed peak capacity and orthogonality 





4.2.1 Buffers and Solutions 
 All solutions were prepared using deionized water (18.3 MΩ, Milli-Q; 
Millipore, Bedford, MA) and filtered with a 0.22 µm nitrocellulose membrane filter 
(Fisher Scientific, Fairlawn, NJ) unless otherwise described. A buffer containing 
300 µM Triton X-100, 1mM TEPA, and 25 mM MES hydrate (Sigma-Aldrich, St. 
Louis, MO) adjusted to pH = 5.50 in 95:5 H2O:MeOH was used for µFFE 
separations of peptide mixtures. A buffer containing 300 µM Triton X-100 and 25 
mM HEPES (Sigma) adjusted to pH=7.00 in H2O was used for µFFE separations 
of amino acid mixtures. Poly(ethyleneoxide) (PEO) (Sigma) was dissolved in 
water to 0.2% by mass with 0.1 M HCl at 95 ˚C for 2 h while stirring. Eluents for 
nLC separations were prepared using LC-MS grade water and LC-MS grade 
ACN, both purchased from J.T. Baker (Phillipsburg, NJ). Trifluoroacetic acid 
(TFA) was purchased from Sigma-Aldrich. For labelling reactions a 10 mM 
NaHCO3 solution (Mallinkrodt, Paris, KY) in water, 10 mg/mL Chromeo™ P503 
(Active Motif, Carlsbad, CA) in DMSO (Sigma-Alrich), 4 mg/mL NBD-F (TCI, 
Portland, OR) in MeOH, and 10 mg/mL Alexa Fluor® 488 TFP ester (Thermo 
Scientific, Waltham, MA ) in 10 mM NaHCO3 buffer were prepared. All amino acid 
standards were purchased from Sigma-Aldrich. Piranha solution                      
(2:1 H2SO4:H2O2) (Ashland Chemical, Dublin, OH) was used to clean glass 
wafers and etch Ti. Caution: Piranha solution self-heats to ~70 ˚C and is 
extremely caustic.  GE-6 (Acton Technologies Inc., Pittston, PA) was used to 
etch Au. Concentrated HF (49%) (Ashland Chemical) was used to etch glass 
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wafers. Silver conductive epoxy (MG Chemicals, Surrey, BC, Canada) was used 
to make electrical connections to the µFFE device. Crystalbond™ 509 (SPI 
Supplies, West Chester, PA) was used to fix fused silica capillaries in the 
completed devices.  
4.2.2 µFFE Device Fabrication  
 The µFFE device was fabricated following the procedure previously 
described by Geiger et. al in Chapter 2.85  Briefly, three rounds of standard 
photolithography were performed to etch features into two 1.1 mm borofloat® 
glass wafers (Precision Glass & Optics, Santa Ana, CA). First, an 85 µm channel 
was etched for the capillary connection. A second etch was performed to etch 30 
µm deep electrode channels. Finally, a third step etched the 1 cm wide × 2.5 cm 
long separation channel to 10 µm in depth.  The final capillary and electrode 
channel depths were 125 µm (~250 µm wide) and 40 µm, respectively.  The CAD 
files used to produce the photolithography masks are shown in Chapter 2, Figure 
2.1.  150 nm Layers of Ti and Au (150 nm) were deposited to one of the wafers 
using a Temescal electron beam evaporator. A photolithography step was then 
performed to pattern the electrodes and remove unwanted Ti and Au. 1 mm 
diameter access holes were drilled in the second wafer for inlet, outlet, and 
electrode connections. A ~90 nm thick layer of amorphous silicon was deposited 
over this wafer. The two wafers were aligned under a microscope and anodically 
bonded (900 V, 3h, 450 ˚C, 5 µbar) using a Karl Suss SB-6 wafer bonder 
(Munich, Germany). The bonded device was cut by the University of Minnesota 
Electrical Engineering/Computer Science Machine Shop to expose the capillary 
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channel. NanoPorts™ (Upchurch Scientific, Oak Harbor, WA) were aligned over 
the access holes and bonded in place using epoxy rings (IDEX, Lake Forest, IL). 
Silver conductive epoxy was used to connect lead wires to the electrodes. The 
device was then heated on a hot plate at ~120ºC while under vacuum. A           
20 µm i.d. × 150 µm o.d. fused silica capillary (Polymicro Technologies, Phoenix, 
AZ) was inserted into the sample channel and Crystalbond™ 509 was pulled 
through the remaining space between the capillary and channel to bond it in 
place. The chip was then perfused with 1M NaOH solution to remove residual 
amorphous silica in the channels. 
4.2.3 Peptide and Amino Acid Labeling 
 Chromeo™ P503 labeling was performed by dissolving 1 nmol of BSA 
digestion standard (Waters Corp., Milford, MA) in 490 µL of NaHCO3 buffer and 
vortexing for 5 minutes. 10 µL of the Chromeo™ P503 dye solution was added 
and the reaction mixture was vortexed for a further 10 minutes. The vial was 
allowed to incubate at room temperature overnight. Alexa Fluor® 488 labelling 
was performed by adding 100 µL of NaHCO3 buffer to a 1 nmol of BSA digestion 
standard and vortexing for 5 minutes. The dissolved digest was then added to a 
vial containing 100 µg of Alexa Fluor® 488 TFP ester and incubated at room 
temperature for 2.5 hours. The final solution was diluted by a factor of 500 prior 
to analysis. For NBD-F labeling 1 nmol of BSA digestion standard was dissolved 
in 466 µL of NaHCO3 buffer. After vortexing 5 minutes, 34 µL of 4 mg/mL NBD-F 
solution in methanol was added and the reaction was incubated at 80ºC for 10 
minutes. Samples for each labeled mixture were filtered using 0.45 µm cellulose 
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acetate syringe filters (Sterlitech, Kent, WA). Amino acid labeling followed similar 
protocols as the protein digests. Briefly, 25 mM solutions of each amino acid 
were prepared and reacted at ratios of dye to amino acid of 4:1, 5:1, and 3:1 for 
Chromeo™ P503, Alexa Fluor® 488, and NBD-F, respectively.  
4.2.4 nano-Liquid Chromatography (nLC) Conditions  
 A Thermo-Dionex UltiMate3000 RSLC nano pump with WPS autosampler 
(Sunnyvale, CA) was used for LC separations. The analytical column (Thermo-
Dionex Part number 164562) was 75 µm i.d. × 15 cm long and packed with 2µm 
Acclaim® PepMap C18 particles. For all separations mobile phase A was 100% 
H2O with 0.1% TFA and mobile phase B was 90:10 ACN:H2O with 0.1% TFA. A 
gradient of 35-55% B over 5 minutes was used to separate peptides labeled with 
Chromeo™ P503 and NBD-F. A gradient of 10-35% B over 5 minutes was used 
to separate Alexa Fluor® 488 labeled peptides. A gradient of 5-85% B was 
applied over 2 minutes to separate Chromeo™ P503 and NBD-F labelled amino 
acids. A gradient of 5-75% B over 2 minutes was used to separate Alexa Fluor® 
488 labelled amino acids. Injection volumes were 0.5 µL for all samples, and the 
flow rate was 300 nL/min. 
4.2.5 Micro Free Flow Electrophoresis (µFFE) Conditions 
 Prior to separations the electroosmotic flow was suppressed by coating 
the µFFE device with PEO following a previously described method.81 For 2D 
separations a syringe pump (Harvard Apparatus, Hollison, MA) was used to 
pump buffer through the separation channel at a total flow rate of 0.5 mL/min 
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(~0.15 cm/sec in the separation channel). 1 mM TEPA (Sigma) was added to the 
separation buffer to further reduce surface adsorption of peptides,.154 Triton X-
100 and 5 % MeOH were added to the buffer to improve stream stability.83 For 
peptide samples +175 V was applied to the right electrode while the left electrode 
was held at ground. For amino acid separations +165 V was applied to the right 
electrode.  
4.2.5 Data Collection and Processing  
 An AZ100 stereomicroscope (Nikon Corp., Tokyo, Japan) mounted with a 
Cascade 512B CCD camera (Photometrics, Tucson, AZ) was used for 
fluorescence imaging. For NBD-F and Alexa Fluor® 488 labelled samples the 
microscope was equipped with a GFP bandpass emission filter cube (Nikon 
Corp) containing two bandpass filters (450-490 nm and 500-550 nm) and a 
dichroic mirror (495 nm cutoff). For the Chromeo™ P503 labelled samples a 
custom filter cube was used (Nikon Corp) containing two bandpass filters      
(470-500 nm and 570-640 nm) and a dichroic mirror (500 nm cutoff). Laser 
induced fluorescence (LIF) detection was performed using a 150 mW, diode 
pumped solid state laser (Coherent) set to 100 mW and expanded into a        
~2.5 cm × ~150 µm line positioned across the separation channel 2 cm from the 
sample inlet. The entire optical setup was enclosed in a light-tight box (Newport, 
Irvine, CA). For on-capillary detection of 1D separations a window was burned 70 
cm down a 100 cm long piece of 20 µm i.d. × 280 µm o.d. fused silica capillary 
(Thermo-Dionex) which was attached to the end of the nLC column using a 
PTFE sleeve. For 2D separations a separate piece of 20 µm i.d. × 280 µm 
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capillary was connected to the capillary in the chip using a ZDV union (Upchurch 
Scientific). The total length from the column to the end of the capillary in the 
µFFE device was 70 cm. The acquisition rate for all separations was 4 Hz using 
a 1× gain for 1D separations and 4× gain for 2D separations. The nLC pump was 
controlled using Chromeleon v6.8 (Thermo-Dionex). Once logged, all data was 
processed using in-house Matlab programs. Cutter v5.0114 and an open source 
program (Peak Finder, available at http://omics.pnl.gov/software) were used to 
process line scans and chromatograms, as well as determine peak capacities. 
For 2D separations the background was corrected using an orthogonal 
background correction as described by Filgueira et. al., with a correction window 
of 50.115 
4.3 Results and Discussion 
Figure 4.1 shows the reactions for three commonly used, fluorescent 
labeling reagents for amines.  Chromeo™ P503 is a fluorogenic chameleon dye 
which targets the amine side chains of lysine and arginine on peptides and 
proteins. The conjugated dye has a positive charge, thus retaining the native 
charge of the labeled molecule.116, 117, 152  NBD-F is a fluorogenic reagent that 
Figure 4.1:  Labeling reactions for primary amines with the fluorophores             
A) Chromeo™ P503, B) NBD-F and C) Alexa Fluor® 488. 
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reacts with primary and secondary amines producing a neutral product.151, 155  
Alexa Fluor® 488 is a sulfonated rhodamine 110 dye with a net -2 charge across 
a typical pH range.156, 157  On closer examination, these reactions clearly have 
the potential to impact sample orthogonality.  Eliminating or even reversing 
positive charges on peptide or amino acid analytes will certainly decrease 
chemical diversity in the mixture.  The size of the labeling reagents is also an 
issue.  Labeling reagents will have little effect on overall size or structure when 
conjugated to a large protein.  When conjugated to a smaller peptide or amino 
acid the relative size of the labeling reagent becomes significant.  The labeling 
reagent may make a larger contribution to the chemical structure and properties 
of the resulting product than the analyte itself, making compounds in the mixture 
much more similar and consequently more difficult to separate. 
Figures 4.2 A-C show 1D nLC chromatograms for BSA tryptic digests 
labelled with Chromeo™ P503, NBD-F or Alexa Fluor® 488.  Differences in the 
chemical properties of the labeling reagents required modification of the mobile 
phase for each separation.  For all dyes the mobile phase gradient was adjusted 
to elute all peaks in a ~5 minute window.  The complexity of the tryptic digest has 
exceeded the peak capacity of the 1D separation with few, if any, baseline 
resolved peaks observed. The average baseline widths of peaks observed 
across the 5 minute separation window were estimated to be 10.0 sec, 9.38 sec, 
and 14.3 sec for the Chromeo™ P503, NBD-F, and Alexa Fluor® 488 labeled 
digests, respectively. Peak capacities for the 1D nLC separations were therefore 
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determined to be 30, 32, and 21 for Chromeo™ P503, NBD-F, and Alexa Fluor® 
488 labeled peptides, respectively (see Table 4.1).  These peak capacities are  
insufficient for a mixture of this complexity considering that a tryptic digest of BSA 
is predicted to produce 74 peptides.  Multiple peptide labelling sites makes an 
even more complex sample possible.  
 
Figure 4.2: 1D nLC chromatograms of A) Chromeo™ P503, B) NBD-F and C) 
Alexa Fluor® 488 labeled BSA tryptic peptides.  2D nLC × µFFE separations of 









 2D nLC × µFFE chromatograms for the same Chromeo™ P503, NBD-F 
and Alexa Fluor® 488 labeled BSA tryptic digests are shown in Figures 4.2 D-F.  
The additional peak capacity provided by coupling with µFFE results in 
separations that better demonstrate the complexity of the mixture with many 
baseline resolved peaks. Figures 4.3-4.5 present the 2D nLC × µFFE 
chromatograms for each labeled digest in more detail.  Figures 4.3-4.5B show 
the minimum convex hull that encloses all of the peaks observed in the 2D 
separations.  The minimum convex hull is a simple, yet powerful method for  
Figure 4.3: A) 2D nLC × µFFE separation of Chromeo™ P503 labeled BSA 
tryptic digest. B) Plot showing the calculation of the minimum convex hull to 
determine the fraction of separation space where peaks elute. Points are the 
elution position of the peaks shown in A).  The red line is the boundary of the 
minimum convex hull that includes all observed peaks. C) Chromatogram 
extracted from the 2D separation shown in A) at 5.50 mm (illustrated by the 
vertical dashed line). D) µFFE linescan extracted line scan from the 2D 








estimating the fraction of separation space where peaks could reasonably be 
expected to elute.53  These plots show clear differences in the observed 
orthogonality of each 2D separation.  The minimum convex hull for the 
Chromeo™ P503, NBD-F, and Alexa Fluor® 488 labelled peptides covered 
48.2%, 52.6%, and 14.6% of the available separation space, respectively.  
Labeling with Chromeo™ P503 and NBD-F effectively retained the sample 
diversity while labeling with Alexa Fluor® 488 negatively impacted the observed 
Figure 4.4: A) 2D nLC × µFFE separation of NBD-F labeled BSA tryptic digest. 
B) Plot showing the calculation of the minimum convex hull to determine the 
fraction of separation space where peaks elute. Points are the elution position of 
the peaks shown in A).  The red line is the boundary of the minimum convex hull 
that includes all observed peaks. C) Chromatogram extracted from the 2D 
separation shown in A) at 7.06 mm (illustrated by the vertical dashed line). D) 
µFFE linescan extracted line scan from the 2D separation shown in A) at 11.9 




orthogonality.  These results are not unexpected considering the reactions shown 
in Figure 4.1. 
Labeling with Chromeo™ P503 dye retains the positive charge at the 
lysine and argenine reaction sites, leaving the pI of the peptides unchanged and 
retaining the chemical diversity of the analyte mixture.117  Peptides with both 
positive and negatively net charges remain after labeling (at pH = 5.5) allowing 
analytes to deflect in both directions in the second dimension µFFE separation.  
Figure 4.5: A) 2D nLC × µFFE separation of Alexa Fluor® 488 labeled BSA 
tryptic digest. B) Plot showing the calculation of the minimum convex hull to 
determine the fraction of separation space where peaks elute. Points are the 
elution position of the peaks shown in A).  The red line is the boundary of the 
minimum convex hull that includes all observed peaks. C) Chromatogram 
extracted from the 2D separation shown in A) at 6.30 mm (illustrated by the 
vertical dashed line). D) µFFE linescan extracted line scan from the 2D 




NBD-F reacts with primary and secondary amines, eliminating cationic 
sites on the peptides (see Figure 4.1).  As a consequence, most analyte peaks 
deflect towards the anode in the µFFE separation indicating that they bear a net 
negative charge (see Figure 5A&B).  Regardless of the inefficient use of µFFE 
separation, peaks still cover 52.6% of the available separation area.  This high 
observed orthogonality may be due to the relatively small size of the NBD label, 
which may have less impact on the chemical properties of the final reaction 
product. 
 Alexa Fluor® 488 reacts with primary amines, replacing a cationic site with 
a double negative charge (see Figure 4.1). As shown in Figure 4.5 A&B, the 
Alexa Fluor® 488 labeled peptides all move towards the anode with little 
separation in the µFFE dimension.  This is not surprising, since the labeling 
reaction effectively makes every peptide in the sample anionic, dramatically 
decreasing chemical diversity in the sample.  Alexa Fluor® 488 is also the largest 
of the labels, which further masks differences in the derivatized analytes. 
Together, the replacement of anionic sites with cationic functional groups and the 
overall size of the Alexa Fluor® 488 label results in a significantly lower observed 
orthogonality than that observed for the Chromeo™ P503 or NBD-F labeled 
digests.   
 Figures 4.3-4.5C show examples of chromatograms extracted from each 
of the 2D separations.  These chromatograms were used to estimate the first 
dimension peak capacity in the 2D separations.  The average observed first 
dimension peak widths were 8.3, 6.8, and 8.8 seconds for the Chromeo™ P503, 
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NBD-F, and Alexa Fluor® 488 labelled peptides, respectively.  The observed first 
dimension peak widths were actually lower than those observed in the 1D nLC 
separations (see Table 4.1) indicating that no peak broadening occurred in the 
nLC to µFFE interface.85  The narrower nLC peaks widths observed in the 2D 
separation may be a consequence of the improved separation.  Estimates of 
peak width are much more reliable when analytes are fully resolved.  LIF 
measurements were collected with a sampling frequency of 4 Hz in the µFFE 
separation channel.  At this acquisition rate, 27-35 data points were recorded 
across each peak, generating the smooth chromatograms observed in Figure 
4.3-4.5C and more than enough to eliminate any peak capacity loss due to under 
sampling.  The measured first dimension peak capacity for the Chromeo™ P503, 
NBD-F, and Alexa Fluor® 488 labelled peptides, was 36, 44 and 34, respectively.  
The NBD-F labeled peptides exhibited better performance on the nLC resulting in 
narrower peaks and a higher observed first dimension peak capacity. 
Table 4.1: Comparison of peak capacity metrics for Chromeo™ P503,  
NBD-F, and Alexa Fluor® 488 labeled tryptic digests of BSA. 
 
Chromeo™ P503 NBD-F Alexa Fluor® 488 
1D nLC Peak Capacity 30 32 21 
1D nLC Observed Peaks 24 33 18 
2D nLC Peak Capacity 36 44 34 
2D µFFE Peak Capacity 30 30 36 
Ideal 2D Peak Capacity 1080 1320 1224 
Fraction Coverage 48.2% 52.6% 14.6% 
Adjusted 2D Peak Capacity 521 694 179 





Figures 4.3-4.5D show examples of extracted µFFE linescans used to 
estimate the second dimension peak capacity.  Based on average peak widths 
the second dimension peak capacities for the Chromeo™ P503, NBD-F, and 
Alexa Fluor® 488 labelled peptides were 30, 30, and 36, respectively. The higher 
observed peak capacity for the Alexa Fluor® 488 labelled peptides is a result of 
the lower µFFE deflection distances observed in this separation. Hydrodynamic 
broadening, a major source of band broadening in µFFE, scales with the 
deflection distance squared.108  Reducing hydrodynamic broadening, albeit 
through a relatively poor use of µFFE separation space, resulted in narrower 
peaks and a higher peak capacity estimate.  
The ideal 2D peak capacities (i.e. nc,2d = 
1nc × 
2nc) for the Chromeo™ 
P503, NBD-F, and Alexa Fluor® 488 labelled peptides were estimated to be 
1080, 1320, and 1224, respectively.  These ideal peak capacities compare well 
with previously reported peak capacities for LC × LC (793 in 15 minutes)14 and 
UPLC × CE (1400 in 40 minutes)97 that were calculated in a similar manner.  The 
ideal peak capacities of the nLC × µFFE separations are even more impressive 
considering that they were generated in a 5 minute separation window.  Our   
nLC × µFFE separations generated 216 – 264 peaks/minute, >4-fold greater than 
previously reported LC × LC separations.  
The ideal peak capacities estimated for the Chromeo™ P503, NBD-F, and 
Alexa Fluor® 488 labeled peptides show the pitfalls of reporting ideal values that 
do not consider losses due to under sampling or non-ideal orthogonality.  Based 
on ideal peak capacity alone, it would be predicted that the Alexa Fluor® 488 
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labeled peptides would yield the best separation (see Table 4.1).  The 2D 
separations shown in Figure 4.2 clearly show that this is not the case.  Poor 
orthogonality limits the fraction of separation space utilized in the Alexa Fluor® 
488 labeled peptide separations (see Figure 4.5B).  Accounting for orthogonality, 
the corrected 2D peak capacities (see eq. 4.1) of the Chromeo™ P503, NBD-F, 
and Alexa Fluor® 488 labeled peptides were 521, 694, and 179, respectively.  
These values give a more accurate representation of the resolving power of the 
2D nLC × µFFE separations shown in Figures 4.2-4.5.  Even after the correction, 
the Chromeo™ P503 and NBD-F labeled peptides separations still produce 
peaks at an impressive rate of 104 and 139 peaks/minute, respectively.  
 Although the 2D nLC × µFFE separation of NBD-F labeled peptides 
produced the highest peak capacity and fractional coverage of the tested labels, 
the high resolving power of the separation reveals a significant drawback 
associated with this reagent.  The total number of peaks observed in the 2D   
nLC × µFFE separations of Chromeo™ P503, NBD-F, and Alexa Fluor® 488 
labeled peptides were 79, 164, and 98, respectively.  The impressive peak 
capacity generated by the 2D separation of NBD-F labeled peptides is able to 
resolve a large number of peaks.  Unfortunately, a tryptic digest of BSA is only 
predicted to produce 74 peptide fragments.  NBD-F is able to react efficiently with 
both the terminal peptide amine as well as arginine/lysine residues, introducing 
the opportunity for heterogeneous labeling at multiple reaction sites.  This 
heterogeneous labeling produces a mixture that is even more complex than the 
original. Chromeo™ P503 labeling produced a separation with 79 peaks, which 
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closely matches the predicted number of BSA tryptic peptides.  Due steric 
restrictions, Chromeo™ P503 only reacts efficiently with lysine and arginine 
residues, not terminal amines.117, 158, 159  Most tryptic peptides only contain a 
single arginine or lysine residue, limiting the opportunity for multiple labeling 
reactions.   
 Figures 4.6 A-C show 1D nLC separations of a group of 25 amino acids 
that have been labeled by Chromeo™ P503, NBD-F or Alexa Fluor® 488.  As 
shown in Figure 4.1, each of the fluorescent labels is significantly larger than the 
amino acid analytes.  We anticipated that the label would therefore have an 
increased effect on the chemical diversity of the mixture and the resulting 
separation.  As shown in Figures 4.6 A-C, the complexity of the mixture 
overwhelms the peak capacity of the 1D nLC separations. It should be noted that 
fast nLC gradients were employed to elute all peaks in a 1.5-2.0 minute 
separation window.   
 Figures 4.6 D-F show 2D nLC × µFFE separations of the same 25 amino 
acid mixture labeled with Chromeo™ P503, NBD-F or Alexa Fluor® 488.  No 
separation of the Chromeo™ P503 labeled amino acids was observed in the 
µFFE dimension, giving rise to a very low separation orthogonality (see Figure 
4.6D).  Most of the amino acids are neutral at pH = 7.0.  Chromeo™ P503 retains 
the positive charge on the amine, resulting in a reaction product that is also 
neutral and therefore does not migrate in the µFFE electric field.  Another issue 
was the labeling efficiency of Chromeo™ P503.  Due to steric factors Chromeo™ 
P503 does not react efficiently with peptide terminal amines.  Similarly, reaction 
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Figure 4.6: 1D nLC chromatograms of A) Chromeo™ P503, B) NBD-F and 
C) Alexa Fluor® 488 labeled amino acids.  2D nLC × µFFE separations of 
D) Chromeo™ P503, E) NBD-F and F) Alexa Fluor® 488 labeled amino 
acids.  Peaks identified in D) include: (1) Histidine, (2) Leucine/ Lysine/ 
Asparagine, (3) Phenylalanine/Methionine/Taurine/Isoleucine/ β-ABA/ 
Arginine/Serine/Valine/Threonine, (4) Glycine/Alanine, (5) β-Alanine and 
(6) γ-ABA/Cysteine.  Peaks identified in E) include: (1) Histidine, (2) 
Arginine/Lysine, (3) β-Alanine/Alanine/Glutamine/Asparagine, (4) Taurine, 
(5) α-ABA, (6) Glutamic Acid/Aspartic Acid, (7) α-ABA, (8) Glycine, (9) 
Phenylalanine, (10) γ-ABA, (11) Methionine, (12) β-ABA, (13) NBD-OH, 





with certain amino acids was challenging with only 18 of the 25 amino acids 
producing fluorescent products. Of these 18 labeled amino acids most eluted at 
the same time. Surprisingly, resolution was higher in the 2D nLC × µFFE 
separation than the 1D nLC separation, even though almost no orthogonality was 
observed.  The apparent increase in resolution could be due to a difference in 
quantum yield between the nLC mobile phase and the µFFE buffer or surface 
adsorption in the µFFE separation channel which could selectively increase the 
retention time of certain analytes.  
 The Alexa Fluor® 488 labeled amino acids did not separate well using  
nLC × µFFE (see Figure 4.6F).  Alexa Fluor® 488 is not a fluorogenic reagent, 
giving rise to a large reactant peak that dominated the separation.  Alexa Fluor® 
488 is a relatively large label that imparts a -2 charge at the amine reaction site, 
effectively making all analytes in the mixture highly negative with an overall 
size/structure not that different from the unreacted label.  This is observed in 
Figure 4.6F where all analytes are pulled strongly to the anode and are not 
resolved from the excess Alexa Fluor® 488 reagent. 
 As shown in Figure 4.6, only NBD-F labeled amino acids were effectively 
separated using 2D nLC × µFFE.  The addition of second dimension µFFE 
separation increased the resolving power with 17 peaks observed.  In this case 
reaction with the label actually increased the sample dimensionality.  Prior to 
labelling, most of the amino acids bear a net neutral charge and would not be 
expected to separation in the µFFE dimension.  Reaction with NBD-F removes 
the positive charge of the amine reaction site. After reaction with NBD-F, most of 
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the amino acid analytes bear a -1 charge, ideal for µFFE separation.  NBD-F is 
also significantly smaller than Chromeo™ P503 or Alexa Fluor® 488 (see Figure 
4.1), and therefore has less impact on the final structure of the labeled amino 
acids.  With minimal optimization 10 of 25 amino acids were baseline resolved in 
a 75 second separation window.  This narrow elution window is much faster than 
previously reported 1D HPLC amino acids separations 160, 161 and even 
approaches separation times achieved using high-speed CE.162 
 
  
Figure 4.7: A) 2D nLC × µFFE separation of NBD-F labeled amino acids. B) Plot 
showing the calculation of the minimum convex hull to determine the fraction of 
separation space where peaks elute. Points are the elution position of the peaks 
shown in A).  The red line is the boundary of the minimum convex hull that 
includes all observed peaks. C) Chromatogram extracted from the 2D separation 
shown in A) at 5.04 mm (illustrated by the vertical dashed line). D) µFFE linescan 
extracted line scan from the 2D separation shown in A) at 10.27 min (illustrated 




 The 2D nLC × µFFE separation of NBD-F labeled amino acids is 
examined in more detail in Figure 4.7. As shown in Figure 4.7B, the nLC and 
µFFE dimensions are fairly orthogonal with peaks spread across ~36% of of the 
available the separation space.  Improved orthogonality would be expected with 
further refinement of the nLC and µFFE separation modes.  Figure 4.7C shows a 
chromatogram extracted from the 2D separation.  The improved resolving power 
of the 2D separation makes clear identification of individual peaks (compare with 
Figure 4.6B).  The average observed peak width in the nLC dimension was 6.50 
sec, giving rise to a first dimension peak capacity of 12.  Even with the 75 second 
elution time, 26 data points were recorded for each peak, reinforcing that µFFE 
effectively eliminates peak capacity losses due to under sampling.  Figure 4.7D 
shows a µFFE linescan extracted from the 2D separation.  The average 
observed peak width in the µFFE dimension was 0.45 mm, giving rise to a 
second dimension peak capacity of 22.  Combining the observed first and second 
dimensions peak capacities give an ideal 2D peak capacity of 264, again in a 75 
second elution window.  Accounting for orthogonality (eq. 4.1), gives a corrected 
peak capacity of ~95, or 76 peaks/minute. 
4.5 Conclusions 
 2D nLC × µFFE was used to generate high peak capacity separations of 
Chromeo™ P503, NBD-F or Alexa Fluor® 488 labeled peptides and amino acids.  
The choice of labeling reagent significantly affected the performance of the 2D 
separations.  nLC × µFFE separations of Chromeo™ P503 or NBD-F labeled 
BSA tryptic digests achieved corrected peak capacities of 521 and 694, 
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respectively, in a 5 minute separation window.  2D separations of Chromeo™ 
P503 and NBD-F labeled BSA tryptic digests were highly orthogonal, with peaks 
covering nearly 50% of the available separation space.  2D nLC × µFFE 
separations of Alexa Fluor® 488 labeled peptides resulted in relatively poor 
orthogonality and observed peak capacity.  Alexa Fluor® 488 reduced sample 
dimensionality by replacing the positively charged amine reaction site with a -2 
charged fluorophore, effectively making all of the peptides anionic.  Although  
nLC × µFFE separations of NBD-F labeled peptides showed the highest peak 
capacity, heterogeneous labeling at multiple labeling sites made the sample 
unnecessarily complex.  Chromeo™ P503 was identified as the preferred 
labeling reagent for peptides due to the combination of high peak capacity and 
homogenous labeling efficiency. 
Of the labels assessed, NBD-F performed the best for 2D nLC × µFFE 
separations of amino acids.  A corrected 2D peak capacity of 90 was achieved in 
a 75 second elution window.  Moderate orthogonality was observed with peaks 
covering 36% of the available separation space.   Chromeo™ P503 labeled 
amino acids did not separate in the µFFE dimension since they remained neutral 
after reaction.  Modification to a µFFE separation mode better suited for the 
separation of neutrals (e.g. MEKC) could address this issue.  2D nLC × µFFE 
separations of Alexa Fluor® 488 labeled amino acids performed particularly 
poorly.  The high negative charge imparted on all analytes and the relatively 
large size of the Alexa Fluor® 488 significantly reduced the chemical diversity of 






















Micro free flow electrophoresis (µFFE) is a separation technique which 
can be used for unique applications due to its continuous nature. Separations are 
performed in space, as opposed to time, as laminar flow drives analytes down 
the separation chamber. This continuous nature makes it an attractive option to 
be used as a second dimension in multidimensional separations. The major 
focus of this work was the development of a 2D separation platform coupling a 
commercial nano-liquid chromatography (nLC) instrument with an all glass µFFE 
device. Once the technique was demonstrated to be a powerful tool in 
separations of a complex sample, the subsequent chapters studied several 
factors which are important to consider if the technique is going to reach is 
maximum potential as a separation tool, specifically broadening in temporal and 
spatial dimensions and the effect of fluorescent labels on orthogonality. 
In Chapter 2, a new µFFE device was designed and fabricated for 
coupling with nLC. A zero dead volume (ZDV) interface needed to be 
implemented to overcome the remixing of analytes seen using traditional fluidic 
connections. A narrow channel was fabricated down the center of the device to 
allow for a glass capillary to be inserted, resulting in a connection which was 
demonstrated to have no impact on peak broadening through the interface. The 
capillary could easily be removed and replaced in the event of clogging or 
breakages. Once the interface was in place, a Chromeo™ P503 labelled BSA 
digest was separated to test the resolving power of the technique. In a 10 minute 
separation window, a 2D peak capacity of 2,352 was observed. Peak capacity 
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generation over the entire analysis was found to be 105 peak/min, nearly double 
the maximum peak capacity production rate achieved using online LC × LC.33, 34 
During experiments, some peptides were observed to adsorb to the surface of 
the device. However, peak widths were only significantly impacted in the time 
dimension (nLC), not space (µFFE). Additionally, the Chromeo™ P503 label was 
carefully chosen to maintain the sample dimensionality to maximize 
orthogonality. Chapters 3 and 4 further addressed these factors.  
The width of analyte peaks is the determining factor in achieving high 
peak capacities. The adsorption of analytes onto surfaces of columns, capillaries, 
and microfluidic devices often becomes a major source of peak broadening in 
separations of biological samples. In Chapter 3 the surface adsorption of 3 
fluorescent dyes was measured in the temporal and spatial dimensions as they 
moved down the separation channel of the previously designed µFFE device. It 
was demonstrated that surface adsorption does not affect the peak position or 
spatial broadening in µFFE separations, even though broadening in the temporal 
dimension was still taking place. Using a low ionic strength buffer to promote 
adsorption, rhodamine 123 exhibited significant surface interactions, causing 
peak broadening and increased asymmetry in the temporal dimension. 
Broadening and symmetry in the spatial dimension, however, was not observed 
to be different from the other separated dyes. Strong surface interactions were 
further demonstrated by separating Chromeo™ P503 labelled myoglobin and 
cytochrome c. In the spatial dimension, the proteins were well resolved and had 
fairly symmetrical peaks despite permanently adsorbing onto the surface of the 
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separation channel. It is clear that in order to maximize peak capacity the 
adsorption in the temporal dimension must be addressed and minimized with the 
use of surface coatings or buffer additives. In Chapter 2, a PEO coating was 
used in addition to adding 8M urea to the buffer, while in Chapter 4, a PEO 
coating was used with the addition of 1 mM TEPA. 
The high peak capacity capabilities of the nLC × µFFE platform were 
demonstrated in Chapter 2. Chapter 4 took a closer look at how fluorescent 
labels can affect the peak capacity and orthogonality of the separation of 
peptides and amino acids. To date, most of the work using µFFE has relied on 
laser induced fluorescence (LIF) as a detection scheme.148 The use of LIF 
requires the sample either be natively fluorescent or labelled with a fluorescent 
dye. The choice of label was shown to greatly impact separation performance. 
Chromeo™ P503 was shown to perform best in the separations of peptides since 
it does not affect the pI of the peptides, preserving sample dimensionality, and is 
a more selective label compared to NBD-F or Alexa Fluor® 488, rediucing the 
likelihood that the sample would become more complex due to multiple labelling. 
As with the separation in Chapter 2, high peak capacities in this work were 
observed in all separations (>1000 in 5 minutes).  Using the fraction of the 
separation space (48%) utilized by the separation a corrected peak capacity of 
521 was observed for the Chromeo™ P503 labelled sample. Though this label 
worked well for peptides, poor labeling efficiency and the nature of the sample 
made it ineffective for separating amino acids. NBD-F was shown to provide 
adequate orthogonality and generated a corrected peak capacity of 95 in a 75 
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second separation window. The dependence on fluorescence is a current 
limitation for all µFFE applications. However, fluorescent labels can still be used 
effectively if they are chosen appropriately based on the sample of interest.   
5.2 Future Applications 
Micro free flow electrophoresis is a technique that can be applied for a 
wide variety of unique applications. The work presented in this thesis 
demonstrated its use a second dimension to provide high peak capacity 
separations of complex samples. In order to make it a more universal platform, 
there are several areas in which further research and development are needed. 
First, the demonstration of a range of separation modes to a variety of real 
samples would help establish protocols and methods to be applied for real world 
applications and find modes which are most orthogonal. Additionally the cost of 
the devices could be reduced through the recent advancements in 3D printing. 
The proper implementation of mass spectrometry detection is long overdue and 
could provide very powerful information for biological samples. 
5.2.1 Combining Separation Modes 
The appropriate choice of orthogonal separation modes in each dimension 
is critical for obtaining maximum separation performance since the entire 
separation space will be accessible to analytes.44, 47 Combining liquid 
chromatography (LC) with µFFE provides a wide range of separation mode 
combinations which need to be explored and evaluated. Previous work with 
2DLC separations revealed, somewhat surprisingly, that choosing two reversed-
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phase (RP) columns and employing significantly different pH mobile phases 
achieved the highest effective peak capacity when testing various combinations 
of RP, SCX, SEC, and HILIC.51 
As mentioned in Chapter 1, µFFE can be operated in several 
electrophoretic separation modes. Peak capacity for the µFFE second dimension 
separations shown were ~30 (Table 4.1). Implementing µFFIEF in the second 
dimension is predicted to have several advantages over the modes used in this 
work. FFIEF is a higher resolution technique and has been predicted to separate 
proteins and peptides differing by only ~0.2 pI units.78 Peak capacities are 
Figure 5.1: Completed µFFIEF device. Multiple inlets and outlets allow for 
presorted ampholytes to be introduced and multiple fractions to be collected. 
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estimated to be as high as 50, increasing total peak capacity by over 50%. 
Additionally, it is predicted, FFIEF will provide more orthogonal separations, 
possibly making better use of the separation space. FFIEF when combined with 
SEC, for example, would provide a comprehensive 2D separation which would 
be very similar to 2DGE since the first dimension would separate based on size, 
and the second on pI. µFFIEF devices have already been fabricated and 
tested.71, 73, 78, 163 An example of a device for µFFIEF fabricated by similar 
methods to the device used in this work can be seen in Figure 5.1. A device such 
as this one could operate in any of the electrophoretic modes by simply changing 
buffer compositions. In the first dimension varying mobile phases could be used 
across an array of column types to see which combinations provide the greatest 
degree of orthogonality and effective peak capacity. Additionally, it would be ideal 
if these techniques could be applied to more real world samples. For example, 
the current nLC × µFFE method used for NBD-F labeled amino acids has been 
used to separate the amino acids released from 3T3-L1 cells (Figure 5.2). 
Application to protein samples would also advance the technique, though as 










5.2.2 Device Design and Fabrication 
The fabrication of microfluidic devices is often a very labor intensive and 
expensive process. In order to produce the devices used in this work, many 
hours of access to a cleanroom facility was required, which many researchers do 
not have access to. Weeks of fabrication are often required to produce even one 
Figure 5.2: A) Separation of NBD-F labelled amino acids collected from 3T3-L1 
cells.. Standards of ornithine (B) and citrulline (C) were labelled and separated for 
identification in (A). 
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functional µFFE device. Polymeric materials such as PDMS69 and PMMA72 have 
been implemented into devices, but the need for rapid prototyping and one-step 
manufacturing is still highly desired. 3D printing technology has come a long way 
since its original introduction in the mid 1980’s.164 Features of only a few microns 
in height can now be produced in a wide array of polymeric materials.165 The 
ability to generate new designs for µFFE devices and have them fully printed in a 
single day for <$1 are now possible. With this rapid, low cost, production, µFFE 
could be much more accessible to researchers.   
It has been stated many times throughout this thesis that LIF has been the 
primary detection method used in µFFE. Chapter 4 clearly demonstrated the 
impact fluorescent labelling can have on separation performance. Though LIF 
provides unmatched sensitivity, no identification information is provided without 
the use of spiked samples (Figure 5.2), and even then, identity can still be 
uncertain in the case of highly complex samples. Mass spectrometry has been 
the work horse for detection and anlysis of many proteomic samples and its 
integration with traditional 1D separation techniques has allowed for many 
advances. Recently MS detection was implemented in µFFE using nanospray 
MS.80 This method proved useful for continuous separations, however to sample 
the entire separation space required varying the right:left inlet flow ratio over time 
to “scan” the separation region. This technique would not be applicable in 
multidimensional separations since it would not be able to adequately and 
efficiently sample first dimension peaks. A method more similar to how Anderson 
et al.166 coupled CE with western blotting could be more effective. By designing 
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an open-edge µFFE device a membrane mounted to a translational stage could 
be moved across the edge during the separation, and further imaged using 
desorption electrospray ionization or matrix assisted laser desorption ionization 
imaging. 3D printing would be critical in allowing many designs to be rapidly 
fabricated and tested.  
Micro free flow electrophoresis has found its way into many areas of 
research since it was first miniaturized. The types of devices, materials, designs, 
and applications have continued to grow. It is my belief that µFFE will soon 
become a commercially viable option to couple to LC instrumentation. Hopefully 
the groundwork for nLC × µFFE I was able to produce will inspire unique 
applications for the technique and someday lead to a method which can have the 
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